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Abstract 
Acute bacterial skin and skin structure infections (ABSSSI) are common infections 
within the local community, and they result in higher morbidity and health care costs.  
While risk factors for skin and soft tissue infections have been previously evaluated, risk 
factors associated with secondary bloodstream infections (BSI) has not been investigated, 
especially in an intercity patient population with limited health care resources.  In this 
case control investigation, 392 patients consisting of 196 cases (ABSSSI + BSI) and 196 
controls (ABSSSI) were investigated to determine risk for BSI. Both sociodemographic 
and underlying conditions were evaluated.  According to bivariate analysis of cases and 
controls, individuals with ABSSSI + BSI were significantly older (p < 0.001), more often 
male (p = 0.008), and had a higher percentage of abnormal symptoms, such as elevated 
temperature, white blood cell count, and acute renal failure on hospital admission (p < 
0.001).  Individuals with ABSSSI + BSI also had a higher percentage of chronic renal 
failure (p = 0.002), diabetes (p = 0.005), congestive heart failure (p = 0.012), intravenous 
drug use (p =0.012), and a history of prior hospitalization (p < 0.001).  Several of these 
factors remained statistically significant by logistic regression analysis, such as male 
gender aOR of 1.85, 95% CI 1.11-3.66; acute renal failure aOR 2.08, 95% CI 1.18-3.67; 
intravenous drug use aOR 4.38, 2.22-8.62; and prior hospitalization aOR 2.41, 95% CI 
1.24-4.93.  This study contributes to positive social change by identifying patient 
characteristics that are associated with ABSSSI-related BSI, thus providing health care 
providers the ability to improve patient outcomes in this underserved patient population. 
  
  
 
Risk Factors and Outcomes for Bloodstream Infections Among Patients with Skin 
Infections 
by 
Michael J. Rybak 
 
MPH, Wayne State University, 2005 
PharmD, Wayne State University, 1981 
BSPharm, Northeastern University, 1979 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 
Doctor of Philosophy 
Public Health 
 
 
Walden University 
December 2016 
  
Dedication 
This dissertation is dedicated to my family for their unwavering support over the 
last 5 years.  I would like to thank them for all of the time I needed to work on this degree 
program including the late evenings, early mornings, and time spent away from family 
outings and vacations.  This was especially true in the case of my wife who despite these 
hardships was always encouraging and supportive of me.  I will always be grateful to 
them for allowing me to achieve this personal goal. 
  
Acknowledgments 
I would like to thank my committee members, Dr. Araon Mendelsohn, who 
served as my committee chair and my committee members, Dr. Vasilleios Margaritis and 
Dr. Pat Carmoney, for their advice, expertise, and excellent and timely reviews of my 
dissertation.  I would like to especially thank Dr. Mendelsohn who was an excellent 
dissertation chair.  Dr. Mendelsohn always made time to take my call and offer advice 
and encouragement.  Thank you Dr. Maragritis for your excellent advice on my 
dissertation chapters and the statistical analysis.   
I would also like to thank Dr. Evan Zasowski, a postdoctorate research fellow in 
my laboratory at Wayne State University for his willingness to discuss my data analysis 
and for his suggestions for recoding data and analyzing some of the variables in my 
study.  Lastly, I would like to thank my family members and all of my friends who have 
supported me through this journey to completed this doctorate degree. 
 
 i 
Table of Contents 
List of Tables ..................................................................................................................... iv	
List of Figures ......................................................................................................................v	
Chapter 1: Introduction to the Study ....................................................................................1	
Introduction ....................................................................................................................1	
Background ....................................................................................................................2	
Problem Statement .........................................................................................................5	
Purpose of the Study ......................................................................................................6	
Research Questions and Hypothesis ..............................................................................8	
Theoretical and Conceptual Framework ......................................................................10	
Nature of the Study ......................................................................................................11	
Definition of Terms ......................................................................................................12	
Assumptions .................................................................................................................15	
Limitations and Scope of the Study .............................................................................15	
Significance of the Study .............................................................................................17	
Summary ......................................................................................................................17	
Chapter 2: Literature Review .............................................................................................19	
Introduction ..................................................................................................................19	
Literature Search Strategy ............................................................................................20	
Theoretical Foundation ................................................................................................21	
Skin and Soft Tissue Infections ...................................................................................23	
Pathogens Responsible for Acute Bacterial Skin and Skin Structure Infections .........25	
 ii 
Community-Associated, Methicillin-Resistant Staphylococcus Aureus ......................26	
Investigations Evaluating Acute Bacterial Skin and Skin Structure Infections ...........30	
Skin- and Soft Tissue-Associated Complications ................................................. 33	
Infections Secondary to Acute Bacterial Skin and Skin Structure 
Infections ................................................................................................... 35	
Socioeconomic Factors Contributing to Infection ................................................ 38	
Summary ......................................................................................................................40	
Chapter 3: Research Method ..............................................................................................42	
Introduction ..................................................................................................................42	
Research Design and Rationale ...................................................................................43	
Summary of Variables by Research Question ...................................................... 45	
Population ............................................................................................................. 48	
Sample Selection ................................................................................................... 48	
Procedures for Data Access .........................................................................................50	
Sample Size ..................................................................................................................50	
Operationalization ........................................................................................................52	
Variable Definitions .............................................................................................. 52	
Data Analysis Plan .......................................................................................................57	
Threats to Validity .......................................................................................................59	
Ethical Procedures .......................................................................................................60	
Summary ......................................................................................................................61	
Chapter 4: Results ..............................................................................................................62	
 iii 
Introduction ..................................................................................................................62	
Data Collection ............................................................................................................62	
Results ..........................................................................................................................65	
Research Question 1 and Hypothesis .................................................................... 65	
Research Question 2 and Hypothesis .................................................................... 73	
Summary ......................................................................................................................77	
Chapter 5: Discussion, Conclusions, and Recommendations ............................................79	
Introduction ..................................................................................................................79	
Interpretation of Findings ............................................................................................80	
Research Question 1 ............................................................................................. 80	
Research Question 2 ............................................................................................. 82	
Theoretical Framework ................................................................................................83	
Limitations of the Study...............................................................................................84	
Recommendations for Future Research .......................................................................85	
Recommendations for Future Action ...........................................................................86	
Implications for Social Change ....................................................................................87	
Conclusion ...................................................................................................................87	
References ..........................................................................................................................89	
 
 iv 
List of Tables 
Table 1. Variables ............................................................................................................. 46	
Table 2. Variables and Tests ............................................................................................. 47	
Table 3. Demographic and Clinical Characteristics of Study Population, n = 392 .......... 64	
Table 4. Demographics, Sociodemographic, and Clinical Characteristics of Cases and 
Controls ..................................................................................................................... 67	
Table 5. Comorbid Conditions, Patient Characteristics, and Clinical Outcomes ............. 69	
Table 6. Logistic Regression Analysis of Patient Risk Factors for ABSSSI+BSI ........... 73	
Table 7. Demographic, Sociodemographic, and Clinical Characteristics by Severity ..... 75	
Table 8. Logistic Regression Analysis of Patient Risk Factors by Severity ..................... 77	
 
 
 v 
List of Figures 
Figure 1. Case and control by zip code ..............................................................................65 
Figure 2. Infection type comparisons between ABSSSI + BSI and ABSSSI ....................70 
Figure 3. Comparison of comorbidities for ABSSSI + BSI and ABSSSI patients ............70 
Figure 4. Comparison of antibiotic treatment for ABSSSI + BSI versus ABSSSI patients71 
 
1 
 
Chapter 1: Introduction to the Study 
Introduction 
Acute bacterial skin and skin structure infections (ABSSSI) are complicated skin 
and soft tissue infections that are caused by bacterial pathogens including resistant 
bacterial organisms, such as methicillin-resistant Staphylococcus aureus (MRSA) that 
were previously susceptible to a variety of common antibiotics.  The Food and Drug 
Administration (FDA, 2013) issued new nomenclature in an effort to define complicated 
skin and skin structures infections.  ABSSSI are complicated skin and skin structure 
infections that generally require hospitalization and parenteral antibiotics and include the 
diagnosis of cellulitis/erysipelas, wound infection, major cutaneous abscess with an 
accompanying redness, or an induration or edema that extends to a minimum lesion 
surface area of 75cm2 (Moran, Abrahamian, Lovecchio, & Talan, 2013).  ABSSSI are 
one of the most common infections in both the community and hospital settings (Amin et 
al., 2014; Pallin et al., 2008; Pollack et al., 2015).  There are a variety of complications 
that can occur secondary to ABSSSI.  One of the most severe complications is 
bloodstream infection (BSI; Lipsky, Kollef, et al., 2010; Suaya, Eisenberg, Fang, & 
Miller, 2013; Tattevin et al., 2012).  While risk factors for ABSSSI have been well 
documented, there is limited information regarding risk for BSI in patients with ABSSSI. 
The purpose of this study was to evaluate the risk factors associated with BSI in 
patients with ABSSSI who reside in intercity Detroit.  Individuals living in the intercity 
with low socioeconomic status are likely to have poor access to health care resources and 
may be at a higher risk for BSI secondary to ABSSSI; this population has not been well-
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studied.  Evaluating this patient population for risk factors for BSI may lead to 
improvement in patient outcomes and potentially reduce the risk for BSI.  This study may 
lead to positive social change because the population that was evaluated has been 
previously shown to be at high risk for complications and increased infection severity. 
 The background for the study, along with supporting evidence from the literature, 
is reviewed in Chapter 1.  The background section is followed by the problem statement, 
the purpose of the study, the dependent and independent variables, and the research 
hypotheses.  Next, the theoretical and conceptual framework is discussed followed by the 
nature of the study.  Definitions of the primary outcome variables, study assumptions, 
and the scope and delimitations are also provided in this chapter.  Lastly, in this chapter, I 
discuss the study limitations, significance of the study, and potential implications for 
social change consistent with the scope of the study.  
Background 
Skin and skin structure infection (SSSI) is a disease of the skin and is defined as 
an infection of the epidermis, dermis, and/or deeper subcutaneous tissues (Dryden, 2010).  
The Infectious Diseases Society of America classify SSSI into a mild infection consisting 
of cellulitis/erysipelas without a purulent focus; moderate infection consisting of 
cellulitis/erysipelas and systemic signs of infection; and severe infections that includes 
failure to respond to previous antibiotic therapy, systemic signs of infection, infection in 
immunocompromised patients and deeper infections involving bullae, necrotizing 
fasciitis, and evidence of organ dysfunction (as cited in Stevens et al., 2014).  The most 
common SSSIs types are cellulitis and erysipelas, which are the diffuse spreading skin 
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infections that are not associated with a suppurative focus.  Abscesses are also common 
and consist of a collection of pus within the dermis and deeper fascia and are often 
associated with inflammation and purulent discharge (Amin et al., 2014).   
The number of patients diagnosed with SSSIs has been steadily increasing in the 
United States over the last decade (Amin et al., 2014; Itani et al., 2011; Tattevin et al., 
2012).  This increase in SSSIs has coincided with rising hospital admissions and 
complications including secondary bone and joint infections, amputations, and BSI (Ray, 
Suaya, & Baxter, 2013a; Suaya et al., 2013).  BSIs are considered one of the most severe 
complications of ABSSSI as BSI carries a significant risk for morbidity and mortality 
(Lipsky, Kollef, et al., 2010; van Hal et al., 2012).  The most common bacterial pathogen 
associated with BSI secondary to ABSSSI is Staphylococcus aureus (S. aureus).  S. 
aureus are now commonly resistant to penicillin and other beta-lactam antibiotics making 
it more challenging for clinicians to appropriately treat these infections.  These organisms 
are collectively referred to as methicillin-resistant S. aureus (MRSA) and make up more 
than 50% of all S. aureus strains associated with infections encountered in the community 
(Ray, Suaya, & Baxter, 2012).   
Community-associated MRSA infections (CAMRSA) are associated with 
ABSSSI, and the prevalence of these infections has increased over the last decade in the 
United States (Moran et al., 2006; Pallin et al., 2008).  In a retrospective study of 
133,450, Ray et al. (2012) evaluated S. aureus isolates obtained from patients with 
infections from a large U.S. integrated health care organization over the years 1998-2009.  
During this time period, the prevalence of MRSA infections increased from 9% to 49% 
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between the years of 1998 until 2005 and decreased slightly from 49 to 43% between 
2006 and 2009 (Ray et al., 2012).  This overall increase in MRSA was most often seen in 
BSI specimens and was most pronounced in individuals who were 18-49 years of age and 
African Americans (Ray et al., 2012).  The largest increase in MRSA was observed from 
community-associated infections, and the increase in MRSA was disproportionately 
higher in African American and Hispanic American patients compared to European 
American patients (Ray et al., 2012).  In addition, after adjusting for other demographic 
factors, Ray et al. found that that African Americans and individuals of low 
socioeconomic status were at increased risk of MRSA infection (Ray et al., 2012).  The 
rise in MRSA infections over the last 10-15 years was largely due to the increase in 
CAMRSA across the United States (Moran et al., 2013).  While the relationship between 
CAMRSA as and ABSSSI has been described, the relationship between CAMRSA and 
BSI has not been well characterized.  In an effort to evaluate this relationship, Tattevin et 
al. (2012) evaluated risk factors and outcomes for 549 patients with BSI caused by 
epidemic MRSA strains of which 55% were CAMRSA.  Although the rates of mortality 
between MRSA and CAMRSA strains were similar, two risk factors for CAMRSA BSI 
were identified: concurrent SSTI and the use of antibiotics within the previous 30 days 
(Tattevin et al., 2012).  Interventions that could reduce SSTI caused by CAMRSA could 
help to reduce the prevalence and severity of CAMRSA BSI (Tattevin et al., 2012).   
A gap in knowledge exists and further characterization of patients who have 
ABSSSI is warranted to determine the risk factors associated with BSI.  In addition, there 
is limited to no information on the relationship of ABSSSI, BSI, and socioeconomic 
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status.  Information derived from this study may lead to improved outcomes in a patient 
population at a higher risk for complications secondary to ABSSSI associated BSI. 
Problem Statement 
ABSSSI are one of the most common infections encountered in community and 
health care settings (Dryden, 2010; Edelsberg et al., 2009).  These infections are 
associated with many complications including bloodstream infections (Bassetti et al., 
2012; Klevens et al., 2007).  Patients with serious ABSSSI require hospitalization.  Of 
those hospitalized, cellulitis and abscess are the most common types of ABSSSI and 
accounted for as many as 597,000 admissions or 1.5% of all hospitalizations in the 
United States in 2006 (Itani et al., 2011).  S. aureus is one of the most common bacterial 
pathogens that cause ABSSSI (Dryden, 2009).  The rate of CAMRSA as a cause of 
increased ABSSSI has increased, accounting for over 3 million annual emergency 
department visits and a prevalence of over 80% in some areas of the United States 
(Mistry et al., 2014; Pallin et al., 2008).   
Certain patient populations may be at higher risk for infectious disease 
complications and poor treatment outcomes (Holman et al., 2011; Khabbaz, Moseley, 
Steiner, Levitt, & Bell, 2014; Moore, Keruly, & Bartlett, 2012).  For example, the rates of 
invasive community-associated MRSA infections are higher among African Americans 
compared to European Americans and in individuals with lower socioeconomic status in 
the United States (Klevens et al., 2007).  In addition, investigators evaluating African 
Americans of low socioeconomic status have reported a higher rate of persistent infection 
burden, higher hospital readmission rates, and increased risk of infection complications 
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including sepsis severity (Acosta et al., 2013; Morris et al., 2014; Zajacova, Dowd, & 
Aiello, 2009).  
One of the worst worrisome complications of ABSSSI is bacteremia (Bassetti et 
al., 2012; Lipsky, Tabak, et al., 2010).  Bacteremia secondary to ABSSSI was previously 
reported as infrequent.  However, bacteremia can occur in up to 20% of patients with 
severe ABSSSI (Lipsky, Tabak, et al., 2010).  Because bacteremia is associated with 
higher rates of mortality, several investigators have attempted to identify patient 
characteristics that are associated with bacteremia in patients with ABSSSI (Bassetti et 
al., 2012; Lipsky, Kollef, et al., 2010; Shurland, Zhan, Bradham, & Roghmann, 2007).  
However, risk factors for bacteremia, including measures of severity of infection, have 
not been evaluated in African American patients with ABSSSI and low socioeconomic 
status in an urban setting.  Therefore, this study was useful in addressing a gap in 
knowledge in the current literature regarding this patient population. 
Purpose of the Study 
 The purpose of this study was to evaluate the health outcomes of patients with 
low socioeconomic status in an urban city environment who had ABSSSI-related S. 
aureus BSI infection.  The primary aim of this investigation was to characterize and 
determine the risk factors for patients with ABSSSI with concomitant BSI compared to 
patients with ABSSSI alone admitted to the Detroit Medical Center and Henry Ford 
Hospital in Detroit, Michigan.  A secondary aim was to determine whether race/ethnicity 
impacted severity of disease in patients with ABSSSI-associated BSI.  While limited 
information is available regarding the risk for ABSSSI among minority patients, there is 
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no information regarding the risk for ABSSSI with concomitant BSI in this patient 
population (Lipsky, Kollef, et al., 2010; Ray, Suaya, & Baxter, 2013b; Suaya et al., 2013; 
Tattevin et al., 2012).  To address this gap, a quantitative methods approach was 
employed.  Assessments were carried out via a case-control study design. The cases 
consisted of patients admitted to the hospital and diagnosed with ABSSSI and S. aureus 
BSI.  The controls were comparable to cases that were admitted to the hospital for the 
diagnosis of ABSSSI, but did not have associated BSI.  The dependent variable was 
ABSSSI with BSI.  Additional dependent variables consisted of rates of mortality, length 
of hospital stay, and secondary complications.  The independent variables that were 
believed to have an impact on whether a patient had ABSSSI or ABSSSI with bacteremia 
included age, race/ethnicity, diabetes, cardiovascular disease, renal failure, recent 
hospitalization, recent MRSA infection, socioeconomic status, alteration in temperature 
and white blood cell count, and receipt of antibiotics in the past 30 days (Lipsky, Kollef, 
et al., 2010; Tattevin et al., 2012).  It was anticipated that characteristics identified by this 
investigation would assist health care providers in improving patient outcomes in this 
underserved population.  The secondary outcome variable was the degree of disease 
severity among patients with ABSSSI associated BSI.  Disease severity was based on 
number and type of surgical interventions.  Covariate variables were the level of income 
and education.  Identifications of these factors can lead to recommendations and 
prevention interventions to improve the health outcomes of patients with ABSSSI in an 
urban environmental setting. 
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Research Questions and Hypothesis 
This study was designed to answer the following research questions: 
RQ1. Are there significant differences in clinical and socioeconomic factors 
between patients with ABSSSI and ABSSSI with BSI in intercity Detroit? 
Subquestions for RQ1 were the following: 
1. Are there significant differences in the distribution of race/ethnicity 
between patients with ABSSSI and patients with ABSSSI- associated 
BSI? 
2. Are there significant differences in age between patients with ABSSSI and 
patients with ABSSSI-associated BSI? 
3. Are there significant differences in the distribution of gender between 
patients with ABSSSI and patients with ABSSSI-associated BSI? 
4. Are there significant differences in education between patients with 
ABSSSI and patients with ABSSSI-associated BSI? 
5. Are there significant differences in income levels between patients with 
ABSSSI and patients with ABSSSI-associated BSI? 
6. Are there significant differences in insurance status between patients with 
ABSSSI and ABSSSI-associated BSI? 
7. Is the presence of a comorbid condition, namely diabetes, renal failure, or 
cardiovascular disease, hepatic diseases, intravenous drug use (IVDU), 
paraplegia, HIV/AIDS, immunosuppression (steroids, radiation, 
chemotherapy) associated with ABSSSI-associated BSI? 
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8. Is alteration of temperature and white blood cell count at baseline 
associated with ABSSSI-related BSI? 
9. Is a recent hospitalization (i.e., within the last 180 days of the present 
hospitalization) associated with ABSSSI-related BSI? 
10. Is a recent hospitalization for MRSA or MSSA infection (i.e., within the 
last 60 days of the present hospitalization) associated with ABSSSI-
associated BSI? 
11. Is receipt of an antibiotic within the last 30 days associated with ABSSSI-
related BSI? 
Ho1: There are no differences in sociodemographic and clinical factors between 
patients with ABSSSI and ABSSSI-associated BSI. 
Ha1: Patients with ABSSSI have different sociodemographic and clinical factors 
compared to patients with ABSSSI-associated BSI. 
RQ2. Is race/ethnicity associated with disease severity (based upon surgical 
interventions [e.g., incision and drainage, wound debridement, amputation]) among 
patients with ABSSSI-related BSI? 
Ho2: Race/ethnicity associated with disease severity (based upon surgical 
interventions, e.g., incision and drainage, wound debridement, amputation, shock or 
admission to the intensive care unit [ICU]) is not different between patients with ABSSSI 
and ABSSSI-associated BSI. 
Ha2: Race/ethnicity associated with disease severity (based upon surgical 
interventions [e.g., incision and drainage, wound debridement, amputation, shock, or 
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admission to the ICU]) is different between patients with ABSSSI and ABSSSI-
associated BSI. 
Theoretical and Conceptual Framework 
The theoretical framework for this study was the web of causation (Krieger, 
1994).  The web of causation conceptual framework is used to explain the association 
between events, the causal agent, and the affected entity.  The web of causation includes 
a link between a preceding event and a subsequent outcome.  The web of causation 
theorists focus on the etiology and provide a process and an explanation for the outcome 
of interest (Aschengrau, 2008; Krieger, 1994).  The cause is a factor that plays a role in 
the disease development.  A disease that develops within a population can be related to 
many different factors including genetic defects, disease causing pathogens, and social 
and behavioral differences or environmental factors (Aschengrau, 2008; Center for 
Disease Control and Prevention [CDC], 2012; Schneider, 2011).  The web of causation 
was used in this investigation to explore the relationship between the patient 
characteristics and the targeted outcome variables between individuals with ABSSSI and 
ABSSSI-associated BSI.  This framework formed the basis for evaluating the differences 
and similarities between patients with ABSSSI and ABSSSI-associated BSI for 
characteristics including race/ethnicity; age; gender; medical insurance status; and 
comorbidities, such as diabetes, renal failure, and cardiovascular diseases.  In addition, I 
measured the severity of illness by surgical intervention and complications.  I explain the 
web of causation and its relationship to this study further in Chapter 2. 
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Nature of the Study 
A quantitative, case-control study design was chosen to address the primary 
research questions in this study.  Case-control designs are retrospective investigations 
(Hebel, 2006) that are appropriate study designs for evaluating risk factors for patients 
with ABSSSI versus those with ABSSSI with BSI.  Risk factors for BSI in patients with 
ABSSSI hospitalized for skin and soft tissue infections have been previously identified 
(Lipsky, Kollef, et al., 2010; Suaya et al., 2013).  Although identifying social and 
personal factors that could act as potential treatment barriers are suggested to ensure a 
successful patient outcome, risk factors for patients with ABSSSI-associated BSI with 
low socioeconomic status have not been evaluated (Bagger, Zindrou, & Taylor, 2004; 
Itani et al., 2011; Klevens et al., 2007; Pollack et al., 2015; Ray et al., 2012).   
The patient population included in this study was recruited from the Detroit 
Medical Center and Henry Ford Hospital.  The Detroit Medical Center is made up of nine 
hospitals of which five are located in midtown Detroit Michigan.  These hospitals service 
a large group of individuals residing in intercity Detroit Michigan.  The Henry Ford 
Hospital is a major medical center that services a large portion of the population of 
Detroit.   
The primary outcome variable was ABSSSI-associated BSI.  The secondary 
outcome variable was disease severity, which was measured on number and type of 
surgical interventions.  The independent variables evaluated included age; gender; 
race/ethnicity; educational level; income; medical insurance status; comorbid conditions 
including diabetes, renal failure, and cardiovascular disease, and recent hospitalization 
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defined as hospital contact within the last 180 days; and MRSA infection within the last 
60 days.  Descriptive statistics were used to characterize controls and cases.  Continuous 
variables were compared by a student t test if normally distributed and Mann-Whitney U 
test if the normality assumption is not met.  Categorical variables were evaluated using 
chi-square or, as necessary, a two-tailed Fisher’s exact test.  Multivariable analysis was 
performed using multiple logistic regression models.  
Definition of Terms 
Acute bacterial skin and skin structure infections (ABSSSI): ABSSSIs are skin 
infections that include cellulitis/erysipelas, wound infection, and major cutaneous 
abscess.  The lesion is also defined by size with a minimum surface area of 75 cm2.  
ABSSSI excludes burn and diabetic foot infections.  ABSSSI are caused by bacterial 
pathogens and are commonly caused by Staphylococcus aureus including methicillin-
resistant strains and Streptococcus pyogenes.  Less common bacterial strains include 
other Streptococcus species, Enterococcus faecalis, and gram-negative bacteria (Pollack 
et al., 2015). 
Bloodstream infection (BSI): Viable bacteria in the bloodstream with the presence 
of clinical symptoms that are associated with a high degree of morbidity and mortality 
(del Rio, Cervera, Moreno, Moreillon, & Miro, 2009).  Complicated bloodstream 
infection is defined as persistent positive blood cultures obtained 48-96 hours after initial 
blood cultures, persistent fever at 72 h, and skin lesions suggestive of systemic infection 
(Corey, 2009).  Uncomplicated bloodstream infection is defined as a negative blood 
culture secondary to removal of an intravenous catheter, defervescence within 72 hours, 
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no signs of infective endocarditis, absences of prosthetic medical devices, and no 
symptoms of metastatic infection (Fowler et al., 2003).  
Community-associated methicillin-resistant Staphylococcus aureus (CAMRSA): 
CAMRSA strains are S. aureus strains isolated from patients in the community that are 
susceptible to most antibiotics but resistant to the beta-lactam antibiotics.  CAMRSA 
strains are associated with skin and soft tissue infections.  By definition, CAMRSA 
infections occur in patients from the community with no known health care risk factors 
(Klevens et al., 2007; Maree, Daum, Boyle-Vavra, Matayoshi, & Miller, 2007; Pallin et 
al., 2008). 
Complicated skin and soft tissue infections: The most extreme form of skin and 
soft tissue infection that often requires surgical intervention and encompasses a number 
of complications and comorbidities including neutropenia, tissue necrosis, skin ischemia 
burns, and insect and animal bites (Dryden, 2010). 
Methicillin-resistant Staphylococcus aureus (MRSA): MRSA are S. aureus 
bacterial strains that are resistant to beta-lactam antibiotics and have been shown to be 
associated with a higher rate of morbidity and mortality than methicillin-susceptible 
strains.  These strains are often referred to multidrug resistant S. aureus because besides 
beta-lactams, these organisms are typically resistant to a variety of nonbeta lactam 
antibiotics.  MRSA infections are usually associated with a variety of health care risk 
factors (Gordon & Lowy, 2008; Klevens et al., 2007). 
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Methicillin-susceptible Staphylococcus aureus (MSSA): MSSA are S. aureus 
bacterial strains that are susceptible to beta-lactam antibiotics and typically susceptible to 
a wide variety of nonbeta lactam antibiotics (Dryden, 2009). 
Secondary bloodstream infection: The CDC (2015) stated that the primary site of 
infection may have seeded the bloodstream secondarily.  The patient has a recognized 
pathogen cultured from one or more blood cultures and has at least one of the following 
signs or symptoms: fever (> 38.00 C), chills, or hypotension and the organism cultured 
from the blood is not related to an infection at another site (CDC, 2015). 
Skin and skin structure infections (SSSI): SSSIs are described as both 
uncomplicated and complicated infections.  Uncomplicated SSSIs include superficial 
infections, such as cellulitis, simple abscesses, furnucles, and impetigo.  Uncomplicated 
SSSIs can often be treated with surgical intervention or antibiotics.  Complicated SSSIs 
are infections involving deeper soft tissues that require significant surgical intervention.  
These patients usually have concomitant underlying comorbidities that may complicate 
the response to therapy (Itani et al., 2011).  
Skin and soft tissue infections (SSTIs): SSTIs are microbial invasions of the 
epidermidis, dermis, and subcutaneous tissues resulting in inflammatory response and 
infection (Dryden, 2009). 
 A more detailed description of the variables and how they will be analyzed can be 
found in Chapter 3. 
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Assumptions 
 One of the primary assumptions of this investigation was that the prevalence of 
individuals with ABSSSI with BSI who reside in urban Detroit will be adequate enough 
after exclusions criteria are applied to complete the required sample size needed for the 
study.  In addition, I assumed that the subject controls of patients with ABSSSI without 
BSI were representative of the same urban Detroit population from which patients with 
ABSSSI and BSI were collected.  Previous BSI investigations from the Detroit Medical 
Center have identified skin as the infection source in 15.9-35% of MRSA BSI (Kullar, 
Davis, Levine, & Rybak, 2011; Kullar, Rybak, & Kaye, 2013; Murray et al., 2013).  
Therefore, I was comfortable that there was enough ABSSSI-associated BSI to meet the 
study sample size requirements.  With respect to the study controls, although this was not 
a matched case-controlled study, every effort was made to ensure that patients with 
similar demographic and underlying comorbid conditions were collected for both 
ABSSSI and ABSSSI with BSI.  Lastly, I assumed that the data collected from the 
Detroit Medical Center and Henry Ford Hospital electronic patient charts were accurately 
reported and contained all of the information required to carry out the investigation and 
there was no differences in the quality and completeness of the data between cases and 
controls. 
Limitations and Scope of the Study  
 The primary objective of this study was to evaluate and characterize the risk 
factors for BSI in individuals with ABSSSI who reside in urban Detroit and have low 
socioeconomic status.  Data were collected on patients who were diagnosed and treated 
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for ABSSSI at the Detroit Medical Center and Henry Ford Hospital.  Limitations for this 
case-control investigation included the retrospective study design, which can introduce 
potential bias.  Because of the potential for bias, case-control studies are not well suited 
for detecting weak associations (odds ratio < 1.5).  The retrospective design of case-
control studies also make it more difficult to establish a clear temporal relationship 
between the exposure and the outcome (Aschengrau, 2008).  In addition, because of the 
retrospective design of this study, the observations made during this investigation could 
be constrained by the ability to capture accurate and complete information from the 
database maintained by the Medical Center and Henry Ford Hospital.  Another potential 
limitation for this study was the fact that the patients in Detroit treated by the Detroit 
Medical Center and Henry Ford Hospital may not be representative or generalizable to 
the general population or to other urban centers throughout the United States.  The 
epidemiology of MRSA BSI may be dependent on the population (e.g., poor, uninsured, 
etc.) that the Detroit Medical Center and Henry Ford Hospital serves (Tattevin et al., 
2012).  It was also possible that patients may be treated differently (treatment bias) 
depending upon their socioeconomic status (insured versus uninsured, education, income 
levels) , which may impact the severity and overall outcome of the patients included in 
this study (Lipsky, Kollef, et al., 2010).  Specific organisms characteristics may have also 
played a role as some strains of MRSA are more virulent (e.g., CAMRSA) or more drug 
resistant then others, and these organisms maybe more common in the community 
surrounding the Detroit Medical Center and Henry Ford Hospital compared to other 
centers throughout the United States (Tattevin et al., 2012).  The incorporation of 
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inclusion and exclusion criteria and multivariable regression analysis in this investigation 
should have helped control for some of the potential confounder variables that have been 
encountered while conducting this study. 
Significance of the Study 
 ABSSSI are one of the most common infections treated in both hospital and 
community settings.  These infections are not only common, but they are increasing in 
prevalence (Amin et al., 2014; Pallin et al., 2008).  Complications secondary to skin and 
soft tissue infections can be severe and include infection of deep tissues and infections of 
the bone (Moran et al., 2013).  BSI represent one of the most severe complications 
secondary to ABSSSI (Suaya et al., 2013).  Although some limited information on BSI 
secondary to ABSSSI exists, this study provided new insights on the risk of BSI in 
patients with ABSSSI who reside in urban Detroit with low socioeconomic status.  This 
research contributed to positive social change by providing information on patient 
characteristics and risk factors that can be used to improve the health outcomes of this 
patient population.  
Summary 
 ABSSSI are common infections that are increasing in prevalence and are 
associated with the rapid increase in invasive CAMRSA (Moran et al., 2013; Pallin et al., 
2008).  Although patients with ABSSSI are commonly treated in the community, patients 
with severe ABSSSI often require hospitalization.  These patients usually have a variety 
of complications that can include deeper tissue abscesses and infection of the bone and 
underlying comorbidities, such as diabetes and renal failure (Lipsky, Kollef, et al., 2010; 
18 
 
Suaya et al., 2013).   BSIs are associated with a high degree of morbidity and mortality 
(van Hal et al., 2012; Yaw, Robinson, & Ho, 2014).  While there are a limited number of 
studies on BSI in patients with ABSSSI, scholars have not focused on a specific patient 
population.  This aim of this investigation was to evaluate the characteristics and risk 
factors associated with ABSSSI-related BSI in patients residing in urban Detroit 
Michigan.  I also evaluated the impact of race/ethnicity on the severity of ABSSSI-
associated BSI.  The results of this investigation may increase the knowledge, prevention, 
and treatment of ABSSSI-associated BSI in this patient population.  In the next chapter, a 
discussion of the literature regarding this gap in the collective knowledge base, along 
with the theoretical frameworks, for this study, will be discussed. 
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Chapter 2: Literature Review 
Introduction 
ABSSSIs are one of the most common infections encountered in both community 
and health care settings (Pollack et al., 2015; Rajan, 2012).  The overall prevalence of 
ABSSSI is increasing.  For example, the number of emergency department visits for skin 
and soft tissue infections increased from 1.2 million to 3.4 million (a 3-fold increase, P 
for trend < 0.001) from 1993 to 2005 (Pallin et al., 2008).  ABSSSI are most commonly 
treated on an outpatient basis; however, individuals with more severe infections require 
hospitalization.  ABSSSI can be associated with many complications.  These include 
deeper dermis infections requiring significant surgical interventions, infections of the 
bone, gangrene, and amputation.  One of the most severe complications of ABSSSI is 
BSIs (Lipsky, Kollef, et al., 2010; Suaya et al., 2013).  BSIs are associated with a high 
degree of mortality (Lipsky, Kollef, et al., 2010; Suaya et al., 2013).  Mortality secondary 
to BSI has been linked to a number of risk factors, such as old age; immunosuppression; 
comorbid underlying conditions such as diabetes, peripheral vascular disease, liver, and 
kidney failure; and inadequate or inappropriate therapy (Bassetti et al., 2012; Itani et al., 
2011).  Although there are a number of studies on the risk factors for mortality associated 
with bloodstream infections, few scholars have evaluated evaluated skin and soft tissue 
infection as a risk factor for BSI.  Further, these researchers have not focused on ABSSSI 
as a risk for BSI caused by the bacterial pathogen Staphylococcus aureus, and the risk of 
BSI was not evaluated in an urban population with low socioeconomic status.  
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In this chapter, the literature search strategy for this study, the theoretical 
foundation, the literature review related to the key variables and concepts for the study, 
and the overall summary and conclusions are reviewed. 
Literature Search Strategy 
The literature search strategy that was used for this review included multiple 
databases, journals, and online resources.  The review was central to identifying the 
research gap, as well as previous investigations on skin and skin structure infections and 
the secondary complication of BSI.  Walden Library databases (PubMed, MEDLINE, 
ProQuest Health & Medical Complete, Sage Premier, Google Scholar, and Web of 
Science from 2008 – 2015) were explored using search terms such as ABSSSI, SSSI, 
complicated skin and skin structure infections (cSSSI), CAMRSA, BSI, and risk factors 
associated with SSSI BSI, socioeconomic status, health care access, race/ethnicity, 
socioecological and ecological framework, chain of infection, and Web of Causation.  
Additional resources that were explored included the CDC as well as the Medicare and 
Medicaid websites for literature and information on risk factors, complications, treatment 
guidelines, and medical insurance coverage policies with respect to ABSSSIs.   
Articles relevant to the research topic were reviewed and selected for the literature 
review if they met study inclusion criteria including the study date parameters, were not 
redundant with previously selected papers, and supported the literature and research gaps.  
Some select articles from prior to 2008 were included because of their pertinent 
contribution to the study topic and their historical importance because CAMRSA is 
associated with ABSSSI, and the prevalence of this organism was first reported during 
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the later 1990s and early 2000-2005.  The prevalence of this organism and its association 
with ABSSSI continues to increase in the community. 
Theoretical Foundation 
The theoretical framework chosen for this study was selected after exploring 
several theory constructs that were related to behavioral risk, patient risk factors or the 
relationship of events, the causal agent, and the subsequent outcome of interest, which 
was BSIs.  The socioecological model was investigated as a possible framework for this 
study because of the interrelationships between the individual and their community 
(Burke, Joseph, Pasick, & Barker, 2009).  Further, this model included a focus on the 
importance of individual beliefs and behaviors in the context of the social environment 
and its impact on health promotion(Glanz & Bishop, 2010).  Ultimately, individuals are 
responsible for their own health.  However, the social determinants of health and the 
social context in which they live contribute to the individual’s health (CDC, 2014b).  This 
fact is most apparent with minorities (e.g., African Americans, Hispanic 
Americans/Latinos, Native Americans) whose health is more often disproportionately 
affected compared to nonminority populations (European Americans) because of lower 
levels of education, lower socioeconomic status, inadequate housing, and living in 
proximity to unsafe environments (Thomas, 2014).  While the socioecological model can 
be used to establish the link between health behavior and social environmental influence, 
it does not include an examination of patient characteristics that contribute to the risk of 
disease.  In addition, health behavior factors are typically collected prospectively via 
surveys and are not documented in the electronic medical charts.  This would make 
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assessments of health behaviors difficult to analyze as contributors to individual risk of 
BSI.  Therefore, this model was not selected as the theoretical framework for this study.   
Another potential theoretical framework that was evaluated was the chain of 
infection.  This theory includes a description of infection transmission as a chain of 
events.  Breaking any link of the chain could stop the transmission of infection 
(Schneider, 2011).  The components of the chain consist of the pathogen (virus, 
bacterium, fungus, or parasite) causing disease, the reservoir or place in which the 
microorganism resides and thrives and the portal of exit where the infecting organisms 
leaves the reservoir and is then transmitted (mode of transmission) through the portal of 
entry (mucous membrane, wound, etc.) to the susceptible individual (CDC, 2012).  
Although the chain of infection theory is important to understanding the infectious 
process, the focus of this theory is based primarily on breaking the chain of events 
through prevention, epidemiologic surveillance, and interrupting transmission through 
infection control practices.  Infection risk as it relates to patient characteristics including 
underlying disease states that contributes to infection acquisition, complications, and 
patient outcomes is not accounted for with this theory; therefore, this framework was not 
selected for this study.  
The theoretical framework chosen for this study was the web of 
causation(Krieger, 1994).  Causation is explained by the relationship between events and 
the connection between the causal agent and the affected entity.  It links a preceding 
event with a subsequent outcome, emphasizes the mechanism of action, and provides a 
process that leads to the event of interest (Aschengrau, 2008).  The cause can be defined 
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as a condition that plays a role in the development of disease.  The occurrence of a 
disease within a population can be related to genetic abnormalities, microorganisms, 
social structural and behavioral differences, environmental factors, and other associated 
characteristics (Norton, 2015).  The web of causation applied to my research because it 
was not clearly known why patients with ABSSSI went on to develop the complication of 
BSI.  The underlying assumption was that there was a causal pathway that differs from 
patients with ABSSSI versus those with ABSSSI with BSI.  Some of these characteristics 
may have been related to race/ethnicity and access to health care.  In this investigation, I 
determined the underlying characteristics in patients with ABSSSI that were associated 
with BSI in urban Detroit. 
Skin and Soft Tissue Infections 
 ABSSSIs are one of the most common infections treated in the community and 
the hospital environment (Edelsberg et al., 2009; Pallin et al., 2008).  The National 
Hospital Ambulatory Medical Care Survey (NHAMCS, 2011) indicated that diseases of 
the skin and subcutaneous tissue accounted for 3.9% of emergency department visits.  
Further, skin and soft tissue infections were one of the top 20 leading diagnosis 
accounting for 2.4% of all emergency department visits in 2011(CDC, 2011).  
Additionally, in data collected from U.S. emergency departments between the years 1997 
and 2005, researchers indicated that the prevalence of ABSSSI has increased by as much 
as 50% and involving up to 14.2 million patients in 2005 (Hersh, Chambers, Maselli, & 
Gonzales, 2008; Pallin et al., 2008).  
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 ABSSSIs result from an invasion of the epidermis, dermis, and subcutaneous 
tissues by microbial pathogens resulting in an inflammatory response leading to 
erythema, pain, swelling, and often a purulent discharge (Dryden, 2010).  The skin is 
colonized with a variety of microbial flora that can act as an inhibitory barrier to 
pathogenic invading organisms.  When this barrier is compromised via a break in the 
skin, ulcers, burns, traumatic or surgical wounds, or pathogenic organisms can gain 
access and cause infection (Dryden, 2009; Ray et al., 2013a).  SSSIs can be classified as 
uncomplicated and complicated, which are terms that can be useful for describing the 
severity of these infections.  However, SSSI descriptions are more useful to for 
understanding the pathogenesis and designing treatment strategies.  In fact, the term 
ABSSSI was adopted by the Anti-Infective Drugs Advisory Committee in 2010 in an 
attempt to focus on bacterial infections for new antibiotic clinical trials, as well as to 
reduce the ambiguity associated with the term cSSSI that includes bacterial and 
nonbacterial causes, bite wounds, bone and joint infections, diabetic foot infections, and 
catheter-associated infections.  Diagnoses under the term ABSSSI included cellulitis, 
erysipelas, major cutaneous abscess, and burn infections (Rajan, 2012).  Cellulitis is an 
infection of the deep dermis and subcutaneous tissue.  It is characterized by 
inflammation, induration, redness, and poorly demarcated borders.  Erysipelas is a form 
of cellulitis affecting the superficial dermal lymphatic glands, and it differs from cellulitis 
by having raised borders that are sharply demarcated.  Cutaneous abscesses are defined as 
a purulent collection of pus within the dermis of the skin that are often accompanied by 
inflammation, redness, induration, swollen lymph nodes, and fever.  Overall, cellulitis 
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and cutaneous abscess appear to be the most common ABSSSIs encountered in 
community and hospital settings.  In a study evaluating the epidemiology and outcomes 
of 1,096 patients with cSSSI in hospitalized patients, cellulitis was the most common 
accounting for 56.8% of all infections followed by cutaneous abscess (35.1%), skin 
ulcers (10.3%), surgical wounds (8.9%), and diabetic skin wounds at 6.6% (Zervos et al., 
2012).  This finding was further corroborated by Itani et al. (2011) who evaluated 43,201 
patients hospitalized with cSSSI.  Of those patients with Gram-positive bacterial cSSSI, 
49.4% were diagnosed as cellulitis, abscess, or cellulitis with abscess (Itani et al., 2011).  
Further, in an evaluation of a large database from the Kaiser Permanente Medical Care 
Program between the years 2006 to 2009, Ray et al. (2013b) identified 648,699 patients 
with SSSI.  Of these, 63% (405,798) were diagnosed as cellulitis and abscess (Ray et al., 
2013b). 
Pathogens Responsible for Acute Bacterial Skin and Skin Structure Infections 
Although a variety of organisms are capable of causing ABSSSI, Gram-positive 
bacteria such as Staphylococcus aureus and Streptococci species are the most common 
bacterial pathogens.  Under certain circumstances, Gram-negative and anaerobic bacteria 
may be involved, especially in polymicrobial skin and skin structure infections such as 
diabetic foot infections and chronic skin ulcers (Dryden, 2010; Moran et al., 2013).  
Streptococcus species such as Streptococcus pyogenes are the primary cause of cellulitis 
and erysipelas, whereas Staphylococcus aureus are most commonly involved in 
cutaneous skin abscesses.  To evaluate the most common organisms involved in cSSSI, 
Sader et al. (2007) collected 4,674 nonduplicate bacterial isolates from 38 medical 
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centers in the United States over the years 2000-2005 from patients with documented 
cSSSI.  Of these isolates, 48.1% (2,248) were identified as Staphylococcus aureus (S. 
aureus), and 4.2% were beta-hemolytic streptococci (Sader et al., 2007).  The remaining 
bacterial pathogens primarily consisted of Pseudomonas aeruginosa, E. coli, and 
Enterococcal species (Sader et al., 2007).  Of the S. aureus, 43.5% were resistant to the 
semisynthetic penicillin antibiotic methicillin, commonly referred to as MRSA, and 
56.5% were MSSA (Sader et al., 2007).  Infection due to MRSA is problematic because 
penicillins and cephalosporins (known collectively as beta-lactams antibiotics) are not 
effective leaving clinicians with fewer and often more toxic therapeutic choices to treat 
these infections (Rehm & Tice, 2010).  In addition, patients infected with MRSA 
generally have more complicated treatment outcomes including longer hospital stays, 
increased failure rates, higher mortality rates for invasive infections, and increased health 
care costs (Klevens et al., 2007; Ray et al., 2013b).  The overall prevalence of MRSA 
infections is increasing.  In data from a national surveillance network composed of 300 
clinical microbiology laboratories across the United States, Styers, Sheehan, Hogan, and 
Sahm (2006) revealed that MRSA infection rates have increased during the years 1998 to 
2005.  In data collected from a large U.S. health plan database, Ray et al. (2013b) 
reported that MRSA-associated SSSIs increased from 5% in 1998 to 42% in 2005 and 
37% in 2009. 
Community-Associated, Methicillin-Resistant Staphylococcus Aureus 
The CDC (2014a) reported a total of 75,309 invasive MRSA infection cases for 
2012 with an incidence rate of 24 cases (CI 20.64-28.10) per 100,000 population.  This 
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increase in invasive MRSA infections can be contributed to the epidemic rise of 
CAMRSA (Pollack et al., 2015).  Risk factors for hospital-associated MRSA (HAMRSA) 
have been well documented and include hospitalization, recent surgical procedures, 
antibiotic exposure, residence in long-term care facilities, catheters, and medical devices 
including patients with renal dysfunction/hemodialysis and diabetic patients (Pulia, 
Calderone, Meister, Santistevan, & May, 2014; Rehm & Tice, 2010).  Individuals with 
CAMRSA infections, however, are not associated with these traditional risk factors 
(Rehm & Tice, 2010).  Individuals with CAMRSA infections can present with a 
relatively healthy background, such as athletes via sports exposure, individuals associated 
with overcrowded living conditions, poor hygiene, homeless, children in day care, 
incarceration, intravenous drug users, men who have sex with men, individuals with 
advanced age, youth (including newborns), recent contact with an individual with a 
similar skin infection, recent antibiotic exposure in the community, skin abrasions, open 
wounds, lesions attributed to spider bites, diabetes, and peripheral vascular disease 
(Meddles-Torres, Hu, & Jurgens, 2013; Pulia et al., 2014).  Prior to 2000, MRSA was 
considered a rare pathogen associated with community-acquired infections (Moran et al., 
2013).  However, the prevalence of MRSA acquired from the community increased after 
the year 2000.  In a single center study in a Los Angeles emergency department, Moran, 
Amii, Abrahamian, and Talan (2005) revealed that between the years 2000 and 2005, the 
prevalence of MRSA infections derived in the community more than doubled from 29% 
to 64%.  CAMRSA has now been described as the leading cause of SSSI in the United 
States (Hersh et al., 2008; Raygada & Levine, 2009).  In a follow-up study with 422 
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patients evaluated for skin and soft tissue infections from 22 geographically diverse 
emergency departments across the United States, Moran et al. (2006) determined that 
CAMRSA accounted for 59% of SSSI.  In the US Healthcare Cost and Utilization Project 
National Inpatient Sample from 2000-2004, researchers determined that total hospital 
admissions increased by as much as 29% (Edelsberg et al., 2009).  The largest increase in 
CAMRSA infections was among younger patients (< 65 years of age) and for urban 
rather than rural patients (Edelsberg et al., 2009).  During this time period, hospital 
admissions were greatest for patients with more superficial infections, such as cellulitis 
and cutaneous abscess, as opposed to health care-associated deeper infections (Edelsberg 
et al., 2009).  CAMRSA-associated SSSI continues to increase in prevalence.  Using 
ICD-9 codes from the National Ambulatory Medical Care Survey and the National 
Hospital Ambulatory Medical Care Survey, researchers determined that the incidence of 
SSSI increased 84.7% over the years 1997-2002 and 2003-2008 (Meddles-Torres et al., 
2013).  During this time period, the primary infection type was cutaneous abscess, which 
increased by 98.3% over a 5-year period (Meddles-Torres et al., 2013).  The increase in 
CAMRSA infections over the last decade is considered a public health threat (CDC, 
2014a; Edelsberg et al., 2009).    
Compared to HAMRSA, CAMRSA are more virulent carrying a wide range of 
exotoxins that cause tissue necrosis leading to severe disease (Rehm & Tice, 2010).  
Genetically, CAMRSA carries a smaller gene type known as staphylococcal cassette 
chromosome mec (SCCmec) Type IV & V.  This gene cassette is associated with the 
methicillin-resistant phenotype that defines MRSA, but is different from HAMRSA 
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strains carrying the much larger multidrug resistant SCCmec cassette Types I-III (Chua, 
Laurent, Coombs, Grayson, & Howden, 2011).  The most common circulating CAMRSA 
types in the United States over the last 10 years are USA300 and USA400 (Klevens et al., 
2007; Maree et al., 2007; Moran et al., 2013). These strains are defined on the basis of 
their pulse-field gel electrophoresis DNA fingerprint (Chua et al., 2011).  CAMRSA 
strains were first identified and documented in children in the mid-1990s with USA400 
being the predominant strain.  Since that time, USA300 has become the epidemic clone 
strain that common in the United States and is the most common bacterial pathogen 
causing ABSSSI (Chua et al., 2011; David & Daum, 2010; Rehm & Tice, 2010).   
The CDC (2010) defined CAMRSA infections as MRSA infections that occur in 
the outpatient settings where the culture of MRSA has been obtained within 48 hours of 
the hospital admission.  In addition, patients who meet the definition of CAMRSA 
infection do not have a history of MRSA infection or colonization and have no history of 
hospitalization, admission to a nursing home, hemodialysis, or surgery within the past 
year.  These patients also do not have permanent indwelling catheters or medical devices 
that are in contact with the skin (CDC, 2010).  While not a part of the CAMRSA 
definition from the CDC, others have defined CAMRSA on the basis of antibiotic 
susceptibility because, in general, CAMRSAs are susceptible to all antibiotics except 
beta-lactams and are, therefore, methicillin-resistant.  In addition, some researchers 
include the genotype as a part of the definition with CAMRSA containing the novel 
smaller SCCmec IV or V cassette and the lukSF-PV genes, which encodes for the 
Panton-Valentine leukocidin (PVL) toxin.  The PVL toxin is a white blood cell exotoxin 
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and is responsible for some of the most severe CAMRSA infection presentations (Herold 
et al., 1998; Vandenesch et al., 2003).   
Investigations Evaluating Acute Bacterial Skin and Skin Structure Infections 
Since the epidemic of CAMRSA first erupted, a number of studies have been 
conducted to examine the prevalence, risk factors, and health outcomes of patients with 
ABSSSI.  Moran et al. (2006) conducted a prospective prevalence study of adult patients 
with SSTIs who were treated in the emergency departments of the Emergency ID Net, 
which is a network of university-affiliated hospitals from 11 cities across the United 
States.  Individuals who had a purulent SSTI that was less than less than 1 week in 
duration were eligible for enrollment into the study (Moran et al., 2006).  A total of 422 
patients were enrolled into the study (Moran et al., 2006).  Overall, the patients tended to 
be younger in age (median age of 39), more commonly men (62%), and mostly non-
Hispanic blacks (49%; Moran et al., 2006).  Abscess was the most common type of 
infection accounting for 81% of the patients followed by wound at 11% and cellulitis 
with purulent exudate at 8% (Moran et al., 2006).  Staphylococcus aureus was the most 
common pathogen associated with SSTI with MRSA accounting for 59% of patients 
(prevalence range 15-74%; Moran et al., 2006).  The other predominant organisms 
identified were methicillin-susceptible Staphylococcus aureus accounting for 17% and 
streptococcus species (7%; Moran et al., 2006).  Of the 218 MRSA isolates recovered, 
99% were determined to be CAMRSA on the basis of the CDC pulse-field 
electrophoresis definitions (Moran et al., 2006).  Infections with MRSA included recent 
antibiotic use, abscess associated with a spider bite, history of MRSA infections, or close 
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contact with an individual who had a similar SSTI (Moran et al., 2006).  Presence of 
underlying comorbid conditions and race and ethnicity were not associated with MRSA 
skin infections (Moran et al., 2006).  However, when these factors were applied to a 
multivariable logistic regression analysis, Black race and the presence of a skin abscess 
were independently associated with MRSA skin and skin structure infections (Moran et 
al., 2006).  MRSA was the most common organism that was identified with ABSSSI 
across 11 diverse U.S. cities (Moran et al., 2006).   
Maree et al. (2007) conducted a study on CAMRSA infections from 1999 to 2004 
in Los Angeles at the Harbor-UCLA Medical Center.  This hospital system is a tertiary-
care urban, hospital in Los Angeles County.  CAMRSA strains were defined as MRSA 
strains isolated < 72 hours of hospitalization (Maree et al., 2007).  During this time 
period, a total of 352 patients with MRSA cultures were identified.  Of these, 229 (65%) 
were men with a median age of 50 years.  Of these patients infecting organisms, 128 were 
identified as CAMRSA via SCCmec type IV phenotype (Maree et al., 2007).  When 
compared to HAMRSA, patients tended to be younger (48 vs. 54 years; p =0.02) and 
were more likely to have MRSA cultured from wounds, a shorter length of hospital stay 
prior to MRSA culture, and an infection identified after the year 2003 (Maree et al., 
2007).  CAMRSA infections were becoming more commonly encountered, were more 
likely to cause skin and skin structure infections, and tended to be more aggressive 
causing an infection with a higher severity and associated with a longer hospital stay 
(Maree et al., 2007).   
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In a large retrospective study of skin and soft tissue infections, Ray et al. (2013a) 
evaluated the incidence, offending pathogens, and patient characteristics.  Over the years 
2009 to 2011, a total of 376,262 SSTIs were examined.  Of the patients who provided 
cultures (58,794), Staphylococcus aureus was the most common pathogen isolated (81%) 
with 46% of these identified as MRSA (Ray et al., 2013a).  The incidence of SSTI was 
496 per 10,000 person-years and was highest in individuals >65, Native Americans, 
African Americans, individuals identified as multiracial, and individuals with diabetes 
(Ray et al., 2013a).  Asian Americans and Hispanic Americans had a reduced rate of 
SSTIs while African Americans between 18 and 50 years of age were at a 
disproportionately high risk for SSTI compared to European Americans (Ray et al., 
2013a).  In addition, Hispanic American and African American patients were more likely 
to have MRSA identified as the causative pathogen for SSTI compared to European 
Americans (OR: 1.79; CI; 1.67-1.92, OR: 1.24, CI; 1.18-1.31), and Asian American 
patients were less likely to have MRSA (OR: 0.73, CI; 0.68-0.78).  Further, individuals of 
lower income status were at an increased risk of MRSA SSSTI (Ray et al., 2013a).  
Patients with diabetes were found to have approximately twice the rate of SSTI (RR: 
1.93, CI: 1.90 to 1.96) compared those without diabetes (Ray et al., 2013a).  In a posthoc 
analysis evaluating race and ethnicity by age group, Asian Americans and Hispanic 
Americans were found to have lower rates of SSTI at every age group except for children 
less than 5 years of age (Ray et al., 2013a).  When evaluating the age bracket of 18 to < 
65, African Americans had SSTI rates substantially higher (RR: 1.27, CI; 1.23 to 1.31 
compared to European Americans of the same age (Ray et al., 2013a).  However, at all 
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other age brackets, African Americans had SSTI rates similar or lower than European 
Americans (Ray et al., 2013a).  Overall, after adjusting for demographic characteristics, 
the investigators concluded that the risk of SSTI was greatest for individuals with 
diabetes, those of lower socioeconomic status, and children under 5 years of age while 
Asian Americans were of lower risk.  In addition the rate of SSTI varied by both age and 
race/ethnicity and warranted further investigation (Ray et al., 2013a).  
Skin- and Soft Tissue-Associated Complications 
Complications from SSTIs can be severe and include necrotizing infections 
requiring extensive surgery, gangrene, amputation, bone and joint infections (including 
osteomyelitis), bloodstream infections, and sepsis (Dryden, 2010; Lipsky, Tabak, et al., 
2010; Sreeramoju et al., 2011; Wilson et al., 2011).  Using a large repository U.S. health 
care database, Suaya et al, 2013 evaluated 2,227,401 SSTI episodes and their 
complications diagnosed from 2005 to 2010.  The most common SSTI type was abscess 
and cellulitis accounting for 50.5% and 54.4%, respectively, and 10% of these patients 
were diabetics (Suaya et al., 2013).  Compared to diabetic patients, nondiabetic patients 
with SSTIs were more likely to be diagnosed in ambulatory settings (96.2 vs. 88.7%; 
p<0.01; Suaya et al., 2013).  Complications secondary to SSTI were noted to occur more 
than five times higher in patients who had diabetes compared to nondiabetic patients 
(4.9% vs. 0.8%; p<0.01; Suaya et al., 2013).  Osteomyelitis was the most common 
complication in patients with SSTIs diagnosed in ambulatory settings and was more 
commonly observed in patients with diabetes compared to nondiabetic patients (3.3 vs. 
0.4%; p< 0.01; Suaya et al., 2013).  Overall, complications were highest and more severe 
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among the hospitalized patients.  In these patients, bloodstream infections, endocarditis, 
and sepsis were the most common complications occurring in 24.7 and 16.3% of patients 
with and without diabetes, respectfully (Suaya et al., 2013).  The rate of subsequent 
rehospitalizations was nearly double for patients with diabetes compared to nondiabetics 
(15.1% compared to 7.8%, respectfully; Suaya et al., 2013).  Overall, patients with 
diabetes had both higher rates of SSTI complications and subsequent hospitalizations 
(Suaya et al., 2013).   
Lipsky et al. (2010) also evaluated complications in diabetic patients with SSTI.  
A total of 3,030 hospitalized patients with positive bacterial cultures from 97 U.S. 
hospitals over the years 2003 and 2007 were evaluated.  Factors that were significantly 
associated with mortality included the severity of illness upon hospital admission (p< 
0.001), the type of SSTI (cellulitis vs. ulcer vs. surgical infection; p<0.001) and a nonfoot 
SSTI location (p< 0.05; Lipsky et al., 2010).  Patients with skin and soft tissue wound 
infections that had polymicrobial isolates including Pseudomonas aeruginosa or non-
Pseudomonas gram-negative monomicrobial bacteria had a significantly increased 
mortality rate (p< 0.01 and p< 0.001, respectfully; Lipsky et al., 2010).  Severity of 
illness, transfer from another acute care hospital, patients from nursing homes, or 
individuals with wound cultures who demonstrated gram-negative pathogens including 
Pseudomonas aeruginosa and polymicrobial infections including MRSA were associated 
with increased length of stay and hospital costs (Lipsky et al., 2010).  Further, patients 
with SSTI wounds infected with MRSA tended to be more severely ill on clinical 
presentation (Lipsky et al., 2010).  Overall, Lipsky et al. identified significant 
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independent risk factors for prolonged hospital stays: increased costs and mortality.  In 
addition, patients with SSTI who had wounds with MRSA tended to have greater severity 
of illness at clinical presentation (Lipsky et al., 2010).  Scholars identified MRSA, 
diabetes, polymicrobial infections that included gram-negative pathogens, and severity of 
illness on hospital presentation as risk factors for SSTI complications. 
Infections Secondary to Acute Bacterial Skin and Skin Structure Infections 
  In the United States, BSI ranked as the 11th leading cause of death in 2008 
(Minino, Murphy, Xu, & Kochanek, 2011).  Staphylococcus aureus is one of the most 
common pathogens causing BSI in both community and health care settings (Sievert et al., 
2013).  Staphylococcus aureus BSIs are associated with a high degree of complications 
including metastatic spread causing septic arthritis, vertebral osteomyelitis, and infective 
endocarditis (Corey, 2009; del Rio et al., 2009).  Mortality secondary to Staphylococcus 
aureus is significant and ranges from 20-40% (Gould, 2007; Kobayashi, Yokota, 
Takahashi, Arioka, & Fukui, 2014).  There are a variety of risk factors that have been 
associated with the increased risk of mortality secondary to Staphylococcus aureus BSI.  
While conducting a systematic review of predictors of mortality secondary to 
Staphylococcus aureus BSI, van Hal et al. (2012) identified age (1.3 fold increase for 
every decade of life), ethnic origin (27.7/100,000 for European Americans compared to 
66.5/100,000 population for African Americans), and underlying comorbid conditions 
(presence of alcoholism, immunosuppression, cirrhosis, congestive heart failure, cancer, 
chronic renal failure requiring dialysis, as well as the presence of multiple comorbid 
conditions as important factors that predicted mortality).  In addition, the source of 
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infection, and whether Staphylococcus aureus BSI developed in the community versus in 
hospital settings, was also a factor.  Of interest, MRSA BSI had a much higher rate of 
mortality compared to MSSA (van Hal et al., 2012).   
The relationship between MRSA BSI and increased mortality was previously 
documented by Shurland et al. (2007) who evaluated 438 patients with MRSA infections 
at a Veterans Affairs medical center.  Patients with MRSA BSI had a higher mortality risk 
compared to patients with MSSA BSI (RR, 1.7, 95% CI: 1.3-2.4, p< 0.01; Shurland et al., 
2007).  In addition, patients who died from MRSA infections tended to be older, have 
more underlying diseases, and were more likely to have severe sepsis compared those 
patients who survived (Shurland et al., 2007).  SSTIs were listed as one of the most 
common sources of BSI with 29.3% listing MRSA as the causative pathogen versus 
22.5% MSSA (Shurland et al., 2007).   
Contributing to data impacting the outcome of patients with MRSA BSI, Yaw 
(2014), using an observational cohort study design, examined the long-term outcomes of 
patients with MRSA and MSSA bacteremia.  Patients with Staphylococcus aureus BSI 
from July of 1997 to June of 2007 were evaluated for crude survival time.  Although 
infection-related mortality was not statistically different between MRSA and MSSA BSI 
after adjusting for known predictors, such as comorbid conditions, severity of illness, 
cancer, and association with long-term care facilities, patients with MRSA BSI had much 
shorter survival time (14 months, [IQR 1-86] compared to MSSA BSI at 54 months [IQR 
3-105]; hazard ratio 1.46, 95% CI; 1.8-79; p = 0.01; Yaw, 2014).  Yaw et al. concluded 
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that the findings of worsening long-term outcomes had treatment implications for MRSA 
BSI.  
  ABSSSI is a common source of Staphylococcus aureus BSI (Lipsky, Kollef, et 
al., 2010).  In data from the meta-analysis of predictors of mortality in Staphylococcus 
aureus BSI from 41 investigations, Van Hal et al. (2012) indicated that patients with BSI 
secondary to ABSSSI were at an intermediate to moderate risk (2-9 fold increased risk) of 
mortality compared to patients with urinary tract, intravenous catheters, ear, nose, and 
gynecological foci listed as the source of infection.  Since the epidemic spread of 
CAMRSA starting in 2000, strain type USA 300 has become the predominant cause of 
ABSSSI in the United States (Zervos et al., 2012).  The aggressive spread of this organism 
is of importance because CAMRSA is considered a highly invasive pathogen capable of 
infecting individuals without the traditional risk factors for MRSA infections.  As part of a 
surveillance study evaluating the molecular characteristics and clinical characteristics of 
patients infected with Staphylococcus aureus strains from 2000 to 2008, Tattevin et al. 
(2012) identified that the USA 300 strain type accounted for 55% (304/549) of BSIs and 
that this strain type was the predominant MRSA clone causing community-associated 
infections.  In addition, there was a strong correlation (Pearson r = 0.953) between USA 
300 ABSSSI and USA 300 BSI, indicating that USA 300 (CAMRSA) ABSSSI was a 
primary source of BSI and that efforts to control USA 300 ABSSSI may decease 
subsequent BSIs and their patient outcome consequences (Tattevin et al., 2012).  Further, 
Tattevin et al. claimed that USA 300 BSI was now predominantly a community infection 
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and had emerged as a consequence of USA 300 ABSSSI in the poor urban area of San 
Francisco.  
In the only study to determine risk factors among patients with BSI hospitalized 
for SSTI, Lipsky, Kollef, et al. (2010) evaluated a large database of adult hospitalized 
patients from 97 hospitals in the United States from the years 2003 to 2007.  Of the 8,747 
patients evaluated, 1,021 (11.7%) were determined to have BSI (Lipsky, Kollef, et al., 
2010).  Independent predictors of BSI were old age, male sex, comorbidities such as 
coronary heart disease, presence of infected devices of prosthesis, health care-associated 
infections, abnormal vital signs such as respiratory rate, low or high pulse rate, 
temperature less than 35.60C, and abnormal white blood cell counts (p< 0.001; Lipsky, 
Kollef, et al., 2010).  Lipsky, Kollef, et al. identified that risk factors for BSI were 
important for early recognition and to manage complications including morbidity and 
mortality associated with BSI.  The limitations of this study were that (a) Lipsky, Kollef, 
et al. only concentrated on hospitalized patients and, therefore, the findings are not 
generalizable to patients with community infections and (b) patients selected were not 
specific to an urban city setting where access to health and other socioeconomic factors 
could have an influence on the risk factors associated with BSI secondary to ABSSSI 
(Lipsky, Kollef, et al., 2010). 
Socioeconomic Factors Contributing to Infection 
 Socioeconomic factors affect individual health outcomes.  The socioeconomic 
environment of the neighborhood can have both direct and indirect impact on health.  
Direct effects on health include injuries from crime, environmental hazards, and illness 
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from toxic exposures (Khabbaz et al., 2014; Lantz & Pritchard, 2010).  Indirect 
influences on health include chronic exposure to social stressors such as poverty, 
unemployment, and discrimination.  Additional mechanisms that link the socioeconomic 
environment to health include health risk behaviors such as poor diet, physical inactivity, 
and tobacco use and the lack of adequate housing and access to health care services 
(Lantz & Pritchard, 2010).  Certain patient populations may be at higher risk for 
infectious disease complications and worse treatment outcomes (Holman et al., 2011; 
Khabbaz et al., 2014; Moore et al., 2012).  Using data from the National Health and 
Nutrition Examination Survey (NHANES) from 1988 through 1994, Zajacova et al. 
(2009) evaluated socioeconomic status and its relationship to chronic and persistent 
infections including Helicobacter pylori infections, periodontal infections, herpes viruses, 
and hepatitis viruses in 19,275 individuals.  Demographic variables included 
race/ethnicity, education, and income variables (Zajacova et al., 2009).  Across all age 
and race/ethnic groups, the burden of infection was highest among those with the lowest 
education and income (Zajacova et al., 2009).  Independent of education and income, 
non-Hispanic Black adults and Mexican Americans had a significantly higher burden of 
infection compared to non-Hispanic White adults (Zajacova et al., 2009).  In addition, 
investigators evaluating race/ethnicity and low socioeconomic status have reported higher 
hospital readmission rates and increased risk of infection complications including sepsis 
severity highest among African Americans (Acosta et al., 2013; Morris et al., 2014).  The 
rates of invasive CAMRSA infections are highest among Blacks compared to Whites and 
in individuals with lower socioeconomic status in the United States (Klevens et al., 
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2007).  In a study on trends in U.S. hospital admissions for SSTI between 1998 and 2004, 
the highest rates for SSTI admissions were among individuals younger than 65 years of 
age and for urban rather than rural hospitals (32% vs. 11%; Khabbaz et al., 2014; Lantz 
& Pritchard, 2010; Moore et al., 2012).  The higher rates of SSTI among urban hospitals 
is of interest because inner city patient populations are more likely to be diverse, have 
higher rates of poverty, health risk behaviors, and poor access to health care resources 
(Khabbaz et al., 2014; Lantz & Pritchard, 2010; Moore et al., 2012).  In order to make 
improvements in individual health outcomes, it is important to evaluate patients in urban 
settings who have low socioeconomic status and are at high risk for infections and 
complications. 
Summary  
 The pertinent literature regarding ABSSSI, the pathogens responsible for causing 
this infection, and the relationship between ABSSSI and bloodstream infection was 
reviewed in this chapter.  The theoretical framework for this study, web of causation, was 
used to describe the relationship between events and the causal agents producing the 
outcome of intent and identifying the risk factors associated with BSI.  It was not clearly 
known why patients with ABSSSI develop BSI.  However, individuals with ABSSSI who 
reside in urban environmental settings are at higher risk for complications secondary to 
ABSSSI including BSI because of socioeconomic status, race/ethnicity, high risk health 
behaviors, and poor access to health care resources.  Methicillin-resistant Staphylococcus 
aureus is the primary pathogen involved in ABSSSI including patients with secondary 
BSI.  CAMRSA is a highly virulent organism and the most common bacterial pathogen 
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causing infections including ABSSSI in the community.  There have been a number of 
investigations on ABSSSI in recent years.  These researchers have identified risk factors 
for ABSSSI including race, such as African Americans; age (< 65 years); and a number 
of comorbid conditions, such as diabetes.  However, there is little to no information 
regarding patients with ABSSSI and their risk for BSI, and there are no studies on inner 
city adults of low socioeconomic status.  In this chapter, I documented the knowledge gap 
regarding ABSSSI and the risk of BSI, which supported the need to evaluate these risk 
factors.   
In the next chapter, the methods section for the investigation will be described.  
This section includes the research questions that were addressed, the rationale for the 
research design, ethical considerations, patient population, justification for the selected 
sample size, patient characteristics to be collected, and statistical approaches that were 
used to analyze the data. 
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Chapter 3: Research Method 
Introduction 
The purpose of this study was to evaluate the health outcomes of patients with 
low socioeconomic status in an urban city environment who had ABSSSI-related S. 
aureus BSI infection.  The primary aim of this investigation was to characterize and 
determine the risk factors for patients with ABSSSI with concomitant BSI compared to 
patients with ABSSSI alone admitted to the Detroit Medical Center (DMC) and Henry 
Ford Hospital (HFH).  The secondary aim was to determine whether race/ethnicity 
impacted the severity of ABSSSI-associated BSI.   
 A detailed description of the methodology that was used to carry out this 
investigation will be described in this chapter.  In the first section of the chapter, I 
describe the research design and rationale.  Included in this section is a description of the 
dependent and independent variables, the research design, and the research questions and 
their importance for advancing the knowledge about the subject area.  Within this 
chapter, the target population is defined, and the estimated sample size, power and 
desired effect size, sampling procedures, time frame, and the inclusion and exclusion 
criteria are presented.  The procedures that were used for gaining access to the data, data 
collection, and a description of the study participants’ demographics and characteristics 
are also included.  In addition, the research variables are defined and a description of how 
the variable was measured is provided.  Procedures for data cleaning, as well as the 
software for statistical analysis that was used, are described.  The planned statistical 
analysis, rationale for variable inclusion, and procedures for data interpretation are 
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discussed.  Threats to internal and external validity and ethical concerns are also 
discussed.  Lastly, this chapter will provide a summary of the design and methodology, as 
well as a transition statement for Chapter 4. 
Research Design and Rationale 
 An observational, case-control study design was chosen to evaluate BSI 
associated with ABSSSI.  This quantitative research design was selected because it is a 
preferred method for examining the type of research questions and hypotheses testing that 
was performed in this investigation, as detailed below (Aschengrau, 2008; Creswell, 
2009; Song & Chung, 2010).  The primary objective of this investigation was to evaluate 
the risk factors associated with BSI in patients residing in urban Detroit Michigan.  A 
secondary purpose of this investigation was to explore the impact of socioeconomic 
status on the severity of BSI.  Risk factors for BSI in patients who had been hospitalized 
for ABSSSI have been previously evaluated (Lipsky, Kollef, et al., 2010).  However, risk 
factors in patient populations with low socioeconomic settings have not been identified.  
A case-control study design was selected because it is one of the most efficient methods 
to evaluate exposure and disease.  Case-control studies start with the subjects who have 
outcome of interest at the outset of the investigation, and then the investigator looks back 
in time to examine potential causative factors.  After the outcome has been identified, 
subjects with the outcome or disease are categorized as cases, and subjects without the 
outcome/disease are categorized as controls.  By comparing subject characteristics 
including exposure factors between cases and controls, the potential cause and risk 
factors for disease development can be derived.  Compared to cohort studies, case-control 
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studies are better suited for evaluating rare events, are more rapid and less expensive to 
complete, require fewer subjects, and accommodate the assessment of multiple risk 
factors for a single outcome (Song & Chung, 2010).  This study design was considered a 
basic and valid epidemiologic approach to measure the relationship between an exposure 
and disease development(Aschengrau, 2008).  Case-control studies have been routinely 
used to examine risk factors associated with ABSSSI, MRSA, and MRSA BSI (Bassetti 
et al., 2012; Davis et al., 2007; Shurland et al., 2007).  The higher frequency of ABSSSI 
compared to other infections, retrospective design, and the availability of electronic 
medical case documentations limited any resource and time constraints for collecting and 
analyzing data.  The primary dependent (outcome) variable for this investigation was the 
diagnosis of BSI.  The independent variables were patient characteristics and factors that 
may determine whether patients with ABSSSI develop secondary BSI; they included age, 
gender, educational level, income, race/ethnicity, diabetes, cardiovascular disease, renal 
failure, cirrhosis, intravenous drug use, recent hospitalization, recent MRSA infection, 
alteration in body temperature, WBC, and receipt of antibiotics in the past 30 days 
(Lipsky, Kollef, et al., 2010; Tattevin et al., 2012).   
The secondary purpose of this investigation was to evaluate the impact of social 
economic status and the degree of severity associated with ABSSSI-associated BSI.  
Social determinants of health and the social context in which individuals live are 
contributing factors to an individual’s health (CDC, 2014b).  The relationship between 
social determinants and its impact on health has been demonstrated most often in 
minorities such as African Americans, Hispanic Americans/Latinos, and Native 
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Americans.  Individuals with lower socioeconomic status and minimal education levels 
who are living in inadequate housing all have been shown to contribute the individual 
health status (Thomas, 2014).  To determine the impact of socioeconomic status on 
severity of disease, race/ethnicity, age, education level income, and insurance status was 
used as independent variables.  Research questions and the variables that were evaluated 
in this investigation are listed in Table 1 and 2. 
Summary of Variables by Research Question 
1. Are there significant differences in clinical characteristics, risk factors, 
and socioeconomic factors between patients with ABSSSI and ABSSSI-
associated BSI? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
46 
 
 Table 1 
Variables 
   
Variable Independent/De
pendent  
 
Variable Type Statistical Test 
Race/Ethnicity Independent Categorical;  African-American will serve as 
the reference variable, Caucasian,  Hispanic 
and   Other will serve as the other variables 
Chi-Square/Logistic 
Regression 
 
Gender 
 
Independent 
 
Dichotomous; Male/Female 
 
Chi-Square/Logistic 
Regression 
 
Age 
 
Independent 
 
Categorical, 18-35, 36-50, 51-75, > 75 
 
Chi-Square/Logistic 
Regression 
 
Education Independent Categorical, hierarchy variables: < high 
school, H.S. graduate, college graduate, 
graduate school 
 
Chi-Square/Logistic 
Regression 
Income Independent Categorical; hierarchy variable as poverty < 
$24,250, $24,250-$32,500, low income, 
$32,501-$49,999, middle income $50,000-
$100,000 or upper middle income > $100,000-
$200,000 per household of 4 
 
Chi-Square/Logistic 
Regression 
Insurance Status Independent Dichotomous variable, present or absent Chi-Square/Logistic 
Regression 
 
Renal Failure, 
Diabetes, 
Cardiovascular 
Disease, hepatic 
disease, IVDU, 
paraplegia, 
HIV/AIDS, 
immunosuppres
sion (steroids, 
radiation, 
chemotherapy) 
 
Independent Dichotomous variable, present or absent Chi-Square/Logistic 
Regression 
 
Temperature, 
White Blood 
Cell Count 
(WBC) 
Independent Categorical; < 35.60C or > 38.00C, WBC > 11 
x 109 cells/L  
 
Chi-Square/logistic 
Regression  
Recent 
Hospitalization 
within the last 
180 days 
 
Independent Dichotomous; present or absent Chi-Square/Logistic 
Regression 
Recent 
Hospitalization 
for MRSA or 
MSSA infection 
within the last 
60 days 
 
Independent Dichotomous; present or absent Chi-Square/Logistic 
Regression 
Receipt of 
antibiotic within 
the last 30 days 
 
Independent Dichotomous; present or absent Chi-Square/Logistic 
Regression 
ABSSSI-
associated BSI 
Dependent Dichotomous; present or absent Chi-Square/Logistic 
Regression 
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2. Is race/ethnicity associated with disease severity (based upon surgical 
interventions [e.g., incision and drainage, wound debridement, 
amputation]), admission to the ICU, or shock between patients with 
ABSSSI and ABSSSI-associated BSI? 
Table 2 
Variables and Tests 
Variable Independent/Dependent  
 
Variable Type Statistical Test 
Race/ethnicity Independent Categorical; 
African-
American, will 
serve as the 
reference 
variable and 
Caucasian, 
Hispanic and 
other will be the 
other variables 
Chi-
Square/Logistic 
Regression 
Surgical 
intervention, 
incision and 
drainage in 
OR, wound 
debridement 
and 
amputation, 
admission to 
ICU or shock 
Dependent Dichotomous; 
Incision and 
drainage 
present/absent, 
wound 
debridement 
present/absent, 
amputation 
present/absent 
Chi-
Square/Logistic 
Regression 
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Population 
 The population selected for this investigation was patients who were hospitalized 
with the diagnosis of ABSSSI with BSI who were admitted to one of the DMC hospitals 
or HFH located within the city of Detroit.  The DMC and HFH were chosen to collect 
cases and controls for this investigation because this nine-hospital system has a centrally 
located campus located in midtown Detroit and, therefore, services a large section of the 
inner city Detroit patient population.  Cases that were included in this study consisted of 
patients admitted to the DMC and HFH with BSI whom developed within 48 hours of 
admission and whom had ABSSSI identified as the primary infection source.  Study 
controls consisted of patients who were admitted to the DMC and HFH with the 
diagnosis of ABSSSI without BSI.  Patients were excluded if they had the diagnosis of 
burns, gangrene, animal or human bites, and osteomyelitis due to severe complications 
associated with these infections.  Both cases and control patients were identified using the 
International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-
CM] diagnostic codes via the DMC and HFH electronic medical records.  The health care 
records were used to establish the exposure history for each study participant 
(Aschengrau, 2008).  The DMC and HFH electronic medical records are detailed data 
files that describe the patient’s characteristics, laboratory values, diagnosis, progress, and 
patient outcome including discharge status. 
Sample Selection 
 Consecutive cases and controls were selected from January 2010-December 2015 
from the electronic patient chart database of the DMC and HFH urban campuses on the 
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basis of ICD-9-CM diagnostic codes for ABSSSI and BSI.  The time period of 2010-
2015 to collect cases was selected because this period of time was consistent with the 
most recent guidelines for the diagnosis and treatment of SSTIs; therefore, medical 
practice with regards to ABSSSI would be current and consistent (Mistry et al., 2014; 
Moran et al., 2013; Pulia et al., 2014).  Patients admitted to the hospital with the 
diagnosis of ABSSSI or ABSSSI with BSI within 48 hours of admission were considered 
community-associated ABSSSI or ABSSSI with BSI (Lark et al., 2001; Lipsky, Tabak, et 
al., 2010).  Control cases were identified by ICD-9-CM diagnostic codes for SSTIs that 
met the definition of ABSSSI (abscess, cellulitis, abscess with cellulitis, and wound 
infection).  Cases were identified by ICD-9-CM diagnostic codes for BSI for which 
ABSSSI had been identified as the source infection for BSI.  Only community-associated 
ABSSSI was included in this investigation because the primary objective of this study 
was to evaluate the risk for BSI among individuals with ABSSSI from the urban 
community of Detroit.  Therefore, chronic SSSI including decubitus ulcers, hospital-
derived SSSI secondary to surgical wounds, gangrene, amputation, and medical devices 
were not included (Ray et al., 2013a).  Community-associated infection was defined as 
ABSSSI on hospital admission.  Community-associated ABSSSI with concomitant BSI 
was defined as individuals who had ABSSSI with BSI on admission or who developed 
BSI within 48 hours of hospital admission and for which the treating physicians had 
documented that ABSSSI was the source of the BSI (Lipsky, Kollef, et al., 2010; Tattevin 
et al., 2012).  Patients with SSTIs with the diagnosis of necrotizing fasciitis, pyomyositis, 
burns, or ABSSSI secondary to recent surgery were excluded because these infections 
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required immediate surgical intervention or had a high likelihood of poor patient 
outcomes irrespective of concomitant BSI (Micek et al., 2010).  
Procedures for Data Access 
 Access to the medical records of the DMC for the inclusion of cases and controls 
was obtained via an application to the DMC Research Committee.  A separate application 
was made to the HFH Institutional Review Board (IRB).  The application included the 
detailed study protocol, data collection forms, and a description of the number of patients 
as well as the specifics on patient data that were collected.  Once the DMC research 
application was approved, an IRB application approval was obtained from Walden 
University and subsequently from Wayne State University, which served as the IRB for 
Wayne State University and the DMC.  Upon receiving permission to collect data from 
the DMC and IRB approvals from Walden University, Wayne State University, and 
HFH, data collection began.  All data were de-identified to protect the personal 
information of the participants.  Participant data were collected via Internet password-
protected data collection software. 
Sample Size 
 The study population consisted of patients from the DMC urban campus hospitals 
Detroit Receiving Hospital, Harper University Hospital and Sinai-Grace Hospital, and 
HFH who were diagnosed with ABSSSI or ABSSSI with BSI.  The minimum sample 
size for an unmatched case-control study was calculated using the statistical test for 
differences in proportions(Fleiss, 2003) as follows:   
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n = sample size in the case group 
r + 1/r = ratio of controls to cases 
( p ) (1 -  p ) = a measure of variability (similar to standard deviation) 
Zβ = represents the desired power (typically 0.84 for 80% power) 
Zα/2 = represents the desired level of statistical significance (typically 1.96) 
(p1 – p2) = effect size (the difference in proportions) 
 I used a sample size calculation OpenEpi with 1:1 for cases and controls to 
determine a sample size requirement of 187 cases and 187 controls (total sample of 374) 
to reach a power of 0.80 using a 2-sided significance level (1-α) of 0.05 to detect an 
adjusted odds ratio of 2.0 (least extreme OR to be detected) for a factor with a known 
prevalence of 10-20% (diabetes, renal failure, prior antibiotics, recurrent infection; 
Carratala et al., 2003; Lark et al., 2001; Micek et al., 2010; OpenEpi, 2015).  Regarding 
my ability to meet the sample size requirement, I previously described the treatment of 
over 300 patients meeting the definition of ABSSSI infection from a single DMC hospital 
over a 2-year period (2012-2014; Claeys et al., 2015).  Therefore, I was confident that I 
could meet the sample size requirement because I proposed to collect cases from multiple 
DMC hospital and HFH sites over an extended 5-year period.  
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Operationalization 
Variable Definitions 
1. Race/ethnicity was designated as listed in the patient’s medical chart and 
was defined as categorical variables as the following: African American, 
referent group, was compared to European American, Hispanic American, 
and other racial/ethnic groups. 
2. Gender was recorded as listed in the patient’s medical chart and was 
defined as a categorical variable as male or female. 
3. Age was measured in years (mean+/- standard deviation years) and was 
collected from the patient’s medical chart and defined as a continuous 
variable. 
4. Education was derived from the medical chart and was defined as a 
categorical variable as < high school, high school graduate, college 
graduate, and graduate school graduate. 
5. Income was derived from the Census Bureau of Statistics by the patient’s 
zip code (i.e., average yearly household income within zip code).  
6. Insurance status was collected from the medical chart and was defined as a 
dichotomous variable as present or absent. 
7. Comorbid conditions were derived from the medical chart and were 
defined as dichotomous variables: diabetes; with or without end organ 
damage; present or absent, chronic renal failure defined as creatinine 
clearance < 30 ml/min or receiving renal dialysis; present or absent, 
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cardiovascular disease; present or absent, intravenous drug use; present or 
absent, hepatic disease; present or absent, paraplegia; present or absent, 
HIV/AIDs; present or absent, use of steroids equivalent to prednisone 20 
mg per day; present or absent and chemotherapy or radiation (within 30 
days of hospital admission; present or absent. 
8. Charlson comorbidity index score was derived from the patient’s chart and 
was defined as a continuous variable. 
9. Temperature and white blood cell count (WBC) was derived from the 
patient’s medical chart and was defined as continuous variables as 
temperature < 35.60C or > 38.00 C, or 35.6-38.00C and WBC > 11 x 109 
cells/L. 
10. History of recent hospitalization was collected from the medical chart and 
was defined within the last 180 days of the current hospitalization.  These 
data were treated as a dichotomous variable (recent hospitalization present 
or absent). 
11. History of recent hospitalization of MRSA or MSSA infection (within the 
last 60 days) was collected from the medical chart and was treated as a 
dichotomous variable (recent MRSA or MSSA infection present or 
absent). 
12. History of ABSSSI within the last 60 days was defined as a categorical 
variable: present or absent. 
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13. Recent antibiotic exposure within the last 30 days was collected from the 
medical chart and was treated as a dichotomous variable (antibiotic 
exposure–present or absent). 
14. Type of antibiotic exposure (antibiotic class) within the last 30 days was 
collected from the medical chart and was treated as a dichotomous 
variable: present or absent. 
15. Location prior to hospital admission was derived from the patient’s 
medical chart and was defined as community, other hospital, skilled 
nursing facility, rehabilitation center, or other long-term care facility and 
was treated as a categorical variable: present or absent. 
16. Length of hospital stay (days) was defined as a continuous variable. 
17. Surgical intervention an indicator of disease severity was collected from 
the medical chart and was defined as dichotomous variable as surgical 
intervention– incision and drainage, debridement, or amputation: present 
or absent. 
18. Admission to the intensive care unit was defined as a dichotomous 
variable: present or absent. 
19. Length of stay (days) in the intensive care unit was defined as a 
continuous variable. 
20. Type of ABSSSI was defined as abscess, cellulitis, abscess and cellulitis, 
infected wounds, and infections related to medical devices; type of 
ABSSSI was defined as dichotomous variables: present or absent. 
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21. Presence of polymicrobial pathogens was defined as a dichotomous 
variable: present or absent. 
22. Type of organism cultured from infected skin or wound was defined as 
dichotomous variables as MSSA, MRSA, Streptococcus pyogenes, other 
staphylococci species, other streptococci species, Corynebacterium, 
anaerobes (i.e., clostridium), or Gram-negative organisms: present or 
absent. 
23. Date of onset and clearance of bloodstream infection (days) was defined 
as a continuous variable. 
24. Date of source control including drainage, wound debridement, and 
medical device removal was defined as a continuous variable. 
25. Staphylococcus aureus cultured from bloodstream was defined as a 
dichotomous variable: present or absent. 
26. Empiric and definitive (based on culture results) antibiotic therapy was 
defined as dichotomous variables as empiric vancomycin, clindamycin IV 
or PO, ampicillin/sulbactam, trimethoprim/sulfamethoxazole PO, other 
definitive therapy vancomycin, daptomycin linezolid IV or PO, 
ceftaroline, trimethoprim/sulfamethoxazole, clindamycin IV or PO, or 
piperacillin/tazobactam or other: present or absent. 
27. Duration of inpatient antibiotics (days) was defined as a continuous 
variable. 
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28. Clinical outcome at discharge was defined as a dichotomous variable as 
alive, on antibiotics, alive, off antibiotics, left against medical advice 
(AMA), or deceased: present or absent. 
29. Development of complications secondary to ABSSSI infection was 
defined as a dichotomous variable: present or absent. 
30. Development of complications secondary to ABSSSI infection was 
defined as dichotomous variables as endocarditis, nonvertebral 
osteomyelitis, vertebral osteomyelitis, or other metastatic sites of 
infection: present or absent. 
31. Reinfection within 30 days was defined as a dichotomous variable: present 
or absent. 
32. Thirty day follow-up status was defined as dichotomous variables as 
deceased, alive, no readmission, readmission, infection related, 
readmission, non-infection-related, or other: present or absent. 
33. ABSSSI-associated BSI was the primary dependent outcome variable and 
was determined via diagnosis verified in the patient’s medical chart.  
ABSSSI-associated BSI was defined as individuals who had ABSSSI with 
BSI on admission or who developed BSI within 48 hours of hospital 
admission and for which the treating physicians had documented ABSSSI 
as the source of the BSI. 
34. Final clinical outcome was defined as dichotomous variables as success 
with all symptoms resolved and no need for further antibiotics, improved 
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with some symptoms remaining and requiring further antibiotics and 
failure, symptoms remaining or change in antibiotics, or need for further 
surgical intervention.  
Data Analysis Plan 
 Patient characteristics for cases and control patients were collected using the 
password-protected RedCap® data collection software, which is a comprehensive 
research data management system created by Vanderbilt University and hosted by Wayne 
State University.  The online data collection tool included the patient’s coded identifier 
number, demographics such as age and gender, vital signs, patient underlying conditions 
including comorbidities, location prior to hospital admission, laboratory values, and 
ABSSSI and BSI diagnosis.  Data analysis was conducted using SPSS Statistics (Version 
23.0, Armonk, NY: IBM Corp.).  Data entered into RedCap® can be downloaded 
directly into SPSS.  Data cleaning consisted of routine data analysis of the database for a 
variety of potential errors including missing responses, typing and coding errors, removal 
of duplicate data, removing spaces, and fixing dates and times.  Data checks also 
included evaluating the database for data that were out of range, inconsistent, or had 
extreme values.  Any missing values were treated to minimize their impact by assigning a 
suitable value or discarding them using a methodically decision process (e.g., case or pair 
wise deletion).  This study had the following research questions: Are there significant 
differences in clinical and socioeconomic factors between patients with ABSSSI and 
ABSSSI with BSI in intercity Detroit?  Is race/ethnicity associated with disease severity 
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(based on surgical interventions [e.g., incision and drainage, wound debridement, 
amputation]) among patients with ABSSSI-related BSI? 
 With respect to data analysis, descriptive statistics was used to characterize cases 
and controls.  Continuous variables were compared by Student t test if normally 
distributed and Mann-Whitney U test if the normality assumption is not met.  Categorical 
variables were evaluated using Pearson’s chi-square test or, as necessary, a two-tailed 
Fisher’s exact test.  Regarding Research Hypothesis 1, patients with ABSSSI had 
different sociodemographic and clinical factors compared to patients with ABSSSI-
associated BSI, the relationship between sociodemographic and clinical factors and the 
development of BSI was first examined using bivariate tests such as chi-square for 
categorical variables with Yates’ correction where appropriate and Student independent t-
test for continuous variables.  All variables with a p value of < 0.1 in the unadjusted 
analyses were included in a multivariable logistic model, which controls for confounding 
variables (Bursac, Gauss, Williams, & Hosmer, 2008).  A backwards-stepwise 
elimination approach was used to eliminate the variable with the largest p value at each 
step.  The Hosmer-Lemeshow statistic was used to evaluate the predicted and observed 
probability to test for evidence of a lack of a model fit (Paul, Pennell, & Lemeshow, 
2013).  Relationships between the predictor variables (e.g., race/ethnicity; comorbid 
conditions such as renal failure, diabetes, and cardiovascular disease etc.) and BSI were 
evaluated using the odds ratio and corresponding 95% confidence interval.  
Research Question 2 was designed to examine whether race/ethnicity is associated 
with disease severity (based upon surgical interventions [ e.g., incision and drainage, 
59 
 
wound debridement, amputation]).  The impact of race/ethnicity on severity was 
evaluated using multivariable logistic regression.  Bivariate analysis was performed 
initially.  All variables with a p value < 0.1 from the unadjusted analyses were included in 
the logistic model.  A backwards-stepwise elimination approach was used to eliminate 
the variable with the largest p value at each step(Bursac et al., 2008).  The Hosmer-
Lemeshow statistic was used to compare the predicted versus observed values to test the 
goodness of fit (Paul et al., 2013).  The results for Research Question 2 were evaluated 
using the odds ratio and the 95% confidence interval.  For all analyses, a p value of < 
0.05 was considered to be statistically significant. 
Threats to Validity 
 Both internal and external threats to validity may affect the study results.  Internal 
threats include misclassification, which is also referred to as a measurement error, could 
be a threat to the study validity.  Misclassification can occur in the classification of the 
exposure or the disease (Aschengrau, 2008).  In this investigation, comorbid conditions 
and the severity of the conditions such as diabetes, renal failure, and cardiovascular 
disease (exposure) had the potential for misclassification as these conditions were often 
documented via patient history at the time of admission.  In addition, misclassification of 
BSI (disease) was possible because BSI could develop shortly after hospital admission 
and not be recognized at baseline.  In addition, it was possible that BSI could be recorded 
as attributed to ABSSSI when the actual infection source was not detected during hospital 
admission.  With respect to BSI, the diagnosis of BSI was only considered when 
diagnosed within 48 hours of admission and directly attributed to ABSSSI with no other 
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likely source of infection.  External validity threats included investigator interpretation of 
the data including generalization of the data across different populations (Creswell, 
2009).  It was possible that the findings from the population of Detroit were unique and 
not easily generalizable to different patient populations.  It was also possible that 
advancement in technologies including diagnostic techniques may reduce the significance 
of these findings including the associations of patient risk and BSI.  Every effort was 
made in this study to accurately document underlying patient conditions and the 
diagnosis of BSI to avoid exposure and disease misclassification.   
Ethical Procedures 
 To ensure that the research met all human investigational compliance, the 
research proposal was submitted to the Walden University IRB (IRB# 2-17-16 0303767); 
Wayne State University’s IRB (IRB # 010616MIE; 12/14/15), which served as the IRB 
for the DMC; and coordinating IRB for the Henry Ford Hospital IRB (IRB # 10245; 1-8-
16).  In addition, the research proposal was submitted to the DMC Research Committee 
(DMC # 13730; 12/16/15) in order to gain access to the electronic medical record 
database.  An expedited approval was obtained with an informed consent waiver because 
the study was a retrospective design.  All data were de-identified to ensure patient 
confidentiality, and HIPAA guidelines were followed to protect patient rights.  Data were 
collected on an Internet password electronic data collection form (RedCap®) developed 
by Vanderbilt University and hosted by Wayne State University.  The data will be 
maintained for a period of 5 years and then will be destroyed.  
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Summary 
 Research design, methods, plan for data access, sample size requirements, patient 
population, and the planned data analysis were discussed in this chapter.  Access to the 
DMC electronic medical records was obtained through the DMC Research Committee.  
Access to electronic medical records for Henry Ford Hospital was obtained from Henry 
Ford Hospital’s IRB.  In addition, the ethical procedures to protect patient rights were 
described including IRB evaluation and approval and procedures for data protection.  In 
Chapter 4, I will review the purpose, research questions, and the hypotheses for this 
investigation, along with a detailed description of the results including descriptive 
statistics and the results of the bivariate and conditional logistic regression analysis.  
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Chapter 4: Results  
Introduction 
The purpose of this case-control study was to identify the risk factors and health 
outcomes of patients with low socioeconomic status in urban Detroit who had ABSSSI-
related Staphylococcus aureus BSI.  The primary goal of this investigation was to 
identify characteristics in patients with ABSSSI that were associated with the secondary 
development of BSI.  A secondary goal of this study was to evaluate the impact of race 
and ethnicity on the severity of ABSSSI and ABSSSI-associated BSI.  In this chapter, the 
results are depicted starting with the study population descriptive analysis, followed by 
the bivariate and multivariable analysis of the study variables. 
Data Collection 
 A total of 5,267 electronic medical records from the DMC and HFH were 
reviewed from January 2010 to December 2015.  Patients with ABSSSI and ABSSSI 
with BSI had to be diagnosed and admitted within 48 hours of admission to be considered 
a community-acquired infection.  Patients with necrotizing fasciitis, pyomysitis, burns, 
gangrene, recent surgery, secondary to animal or human bites, and osteomyelitis were 
excluded given that these infections can be life threatening, require immediate surgery, 
and/or have nothing to do with risk factors or severity secondary to BSI.  After these 
exclusions, 392 patients met the study criteria for inclusion.  
 The study population of 392 patients consisted of 196 cases (ABSSSI + BSI) and 
196 controls (ABSSSI) with a median age of 47 years (range 18-96 yrs.) and a male 
predominance of 59.2% (see Table 3).  Based on the sample size of 392 collected in this 
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study, the minimum sample size of 374 was exceeded to reach a power of 0.8 for a 2-
sided significance level of 0.05 to detect an adjusted OR of 2.0 for a risk factor with a 
known prevalence of 10-20% as stated in Chapter 3.  With respect to race, African 
Americans made up the majority of the study population at 56.1% followed by  
European Americans at 37.2%, other race/ethnicities at 6.1%, and Asian Americans 
0.5%.  The most common type of ABSSSI was abscess plus cellulitis accounting for 
39.8% of the subjects followed by abscess with 33.2% cases, cellulitis 19.4%, infected 
wound 7.1%, and ulcers contributing to 0.5% of cases.  In terms of sociodemographic 
characteristics by zip code, 6.9% had less than a high school education, 35.7% were 
considered below the federal poverty level in terms of income, and 19.1% had no medical 
insurance.  Figure 1 displays the cases and control distribution per zip code for Detroit 
and non-Detroit areas. 
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Table 3 
Demographic and Clinical Characteristics of Study Population, n = 392 
Variable Population 
Age (yr.), mean, +/- (SD) 48.7 (17.4) 
Gender, n, (%)  
Male 232 (59.2) 
Female 160 (40.8) 
Race, n, (%)  
African-American 220 (56.1) 
Asian 2 (0.5) 
Caucasian 146 (37.2) 
Other 24 (6.1) 
Sociodemographics by zip code, n, (%)  
>30% < high school education 27 (6.9) 
Below poverty level income 140 (35.7) 
No Medical insurance, n, (%) 75 (19.1) 
Type of ABSSSI, n, (%)  
ABSSSI 130 (33.2) 
Cellulitis 76 (19.4 
ABSSSI + Cellulitis 156 (39.8) 
Infected Wound 28 (7.1) 
Ulcer 2 (0.5) 
BMI kg/m2 > 30, n, (%) 170 (43.4) 
Staphylococcus aureus BSI, n, (%)  
Methicillin-susceptible 70 (17.9) 
Methicillin-resistant 126 (32.1) 
Note. Sociodemographic data < 30% high school education and below poverty level 
income were derived per zip code from federal census data.  Status of medical insurance 
was obtained from the individual patient medical chart. 
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Figure 1. Case and control by zip code. Upper panels depict various zip codes from 
Detroit and non-Detroit areas from which cases and controls were derived.  Bottom panel 
displays cases and controls per Detroit zip codes.  Red circles indicate zip codes where 
higher rates of cases were observed 
 
Results 
Research Question 1 and Hypothesis 
1. Are there significant differences in sociodemographic and clinical factors 
between patients with ABSSSI and patients with ABSSSI-associated 
bacteremia in intercity Detroit? 
Ho1: There are no differences in sociodemographic and clinical factors between 
patients with ABSSSI and ABSSSI-associated BSI. 
Figure	1.	Case	and	Control	by	Zip	Code	
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Ha1: Patients with ABSSSI have different sociodemographic and clinical factors 
compared to patients with ABSSSI-associated BSI  
Data analysis by chi-square, Fisher’s exact test, or Student independent t-test, or 
Mann Whitney U test—where appropriate—of demographic, sociodemographic, and 
clinical characteristics for patients with ABSSSI with BSI and ABSSSI are listed in Table 
4.  Individuals with ABSSSI + BSI were significantly older (p< 0.001) and were 
predominately male (p = 0.008) compared to those with ABSSSI.  There were no 
significant differences observed with respect to race or sociodemographic characteristics 
by zip code such as education, median income levels including poverty, or the type or 
presence of medical insurance.  Individuals with ABSSSI + BSI had a higher percentage 
of abnormal temperature, elevated WBC counts, and acute renal failure on hospital 
admission (p< 0.001).  In addition, individuals with ABSSSI + BSI had a higher 
percentage of cellulitis and infected wounds or ulcers whereas individuals with ABSSSI 
had a higher percentage of abscess or abscess in combination with cellulitis (p<0.001).  
Figure 2 displays infection type for those with ABSSSI + BSI and ABSSSI.  Although 
there was no difference in the infection site (e.g., upper versus lower extremity, p = 
0.930), individuals with ABSSSI tended to have a higher rate of methicillin-resistant S. 
aureus (p = 0.004).   
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Table 4 
Demographics, Sociodemographic, and Clinical Characteristics of Cases and Controls 
Variables 
 
ABSSSI + BSI 
n = 196 
ABSSSI 
n = 196 
p Value 
Age (yr.), mean+/-(SD) 52.4 (18.4) 45.3 (15.5) < 0.001 
Gender, n, (%) 
Male 
Female 
 
129 (65.8) 
67 (34) 
 
103 (52.6) 
93 (47.0 
0.008 
Race, n, (%) 
African-American 
Asian 
Caucasian 
Other 
 
112 (57.1) 
1(0.5) 
68 (34.7) 
15 (7.7) 
 
108 (55.1) 
1 (0.5) 
78 (39.8) 
9 (4.6) 
0.520 
Sociodemographics by zip code, n, (%) 
Education >30% No High School 
Median Income < poverty 
Medical Insurance, n, (%) 
 
18 (9.2) 
78 (39.8) 
39 (19.9) 
 
9 (9.6) 
62 (31.6) 
36 (18.4) 
 
0.073 
0.092 
0.399 
BMI>30 kg/m2, n, (%) 79 (41.6) 91 (46.4) 0.340 
Abnormal Temperature, n, (%)  87 (44.4) 38 (19.4) <0.001 
Elevated WBC, n, (%) 138 (60.3) 91 (39.7) <0.001 
Acute Renal Failure, n (%) 98 (50) 48 (24.5) <0.001 
Type of ABSSSI, n (%) 
Abscess 
Cellulitis 
Abscess + Cellulitis 
Infected Wound 
Ulcer 
 
56 (28.6) 
56 (28.6) 
58 (29.6) 
24 (12.2) 
2 (1) 
 
74 (37.8) 
20 (10.2) 
98 (50) 
4 (2) 
0 (0) 
<0.001 
Infection Site, n, (%) 
Upper Extremity 
Lower Extremity 
Head/Neck 
Torso/Trunk 
 
46 (23.5) 
84 (42.9) 
31 (15.9) 
35 (17.9) 
 
65 (33.2) 
83 (42.3) 
20 (10.2) 
28 (14.3) 
0.930 
Methicillin-Resistant S. aureus, n, (%) 126 (64.3) 152 (77.7) 0.004 
Polymicrobial, n, (%) 21 (10.8) 22 (11.2) 0.886 
Note. Chi-square/Fisher’s exact test was used for categorical variables, and Mann-
Whitney U test for continuous variables. 
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Comorbid underlying conditions, patient characteristics, and clinical outcomes are 
listed in Table 5.  As can be seen by the Charlson comorbidity index median and IQR, 
individuals with ABSSSI + BSI tended to have a higher number of underlying conditions 
such as chronic renal failure and diabetes that were associated with 1-year mortality 
compared to individuals with ABSSSI (p< 0.001).  The distribution of comorbid 
conditions between ABSSSI + BSI and ABSSSI are depicted in Figure 3.  The most 
common underlying conditions were diabetes, hypertension, and intravenous drug use.  
Of interest, these three conditions were significantly (p  = 0.003, p = 0.007, p = 0.012, 
respectively) higher in patients with ABSSSI + BSI.  In addition, there were significantly 
more patients with ABSSSI + BSI who had previous hospitalization within 180 days of 
hospital admission (p < 0.001) and who had a prior infection with methicillin-susceptible 
S. aureus within 60 days of hospital admission (p = 0.014).  There were also a higher 
percentage of patients with ABSSSI + BSI who had an infectious diseases consult, were 
admitted to the intensive care unit, and experienced a longer hospital stay (p < 0.001).  In 
addition, patients with ABSSSI + BSI had an increased hospital mortality (p < 0.001), a 
higher clinical failure rate at discharge (p = 0.003), more surgical complications such as 
incision and drainage at bedside (p < 0.001), and a higher amount of reinfection within 30 
days of hospital discharge (p = 0.006).  Antibiotic treatment for ABSSSI and BSI and 
ABSSSI is depicted in Figure 4.  Vancomycin was the most commonly used antibiotic 
overall.  Of interest, a significantly (p = 0.001) higher percentage of patients with 
ABSSSI + BSI were treated with vancomycin compared to those with ABSSSI (79.1 
versus 64.3%).  Clindamycin was the second most common antibiotic administered.  
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Although the use of clindamycin was higher in patients with ABSSSI (27 versus 18.9%), 
this difference was not statistically significant (p = 0.055).  While cephalexin use was 
significantly (p= 0.030) higher in patients with ABSSSI, the overall use was low (6 
versus 0, respectively).  
Table 5 
Comorbid Conditions, Patient Characteristics, and Clinical Outcomes 
 
Variable ABSSSI + BSI ABSSSI p Value 
Comorbid Conditions 
Chronic Renal Failure, n, (%) 
Hepatic Disease, n, (%) 
Diabetes, n, (%) 
Paraplegia, n, (%) 
Hypertension, n, (%) 
Congestive Heart Failure, n, (%) 
IV Drug Use, n, (%) 
 
25 (12.9) 
18 (9.2) 
76 (38.8) 
4 (2) 
88 (44.9) 
19 (9.7) 
44 (22.4) 
 
8 (4.1) 
4 (2.6) 
49 (25.0) 
0 (0) 
62 (31.6) 
7 (3.6) 
25 (12.8) 
 
0.002 
0.005 
0.003 
0.440 
0.007 
0.015 
0.012 
Charlson Comorbidity Index, median, (IQR) 2 (1-5) 1 (0-3) <0.001 
Corticosteroids, n, (%) 2 (1) 1 (0.5) 0.562 
Prior hospitalization 180 days, n, (%) 63 (32.1) 25 (12.8) <0.001 
Prior antibiotic use past 30 days, n (%) 18 (9.2) 16 (8.2) 0.720 
Prior MSSA infection 60 days, n, (%) 6 (3.1) 0 (0) 0.014 
Prior MRSA infection 60 days, n, (%) 11 (5.6) 7 (3.6) 0.334 
History of ABSSSI past 60 days, n, (%) 22 (11.2) 14 (7.1) 0.162 
Clinical Outcomes 
ID Consult 
Admission to ICU, n, (%) 
Length of hospital stay, (d), mean, (SD) 
Clinical failure at discharge, n, (%) 
In hospital mortality, n (%) 
Complications, n (%) 
Surgery, n, (%) 
Incision and drainage at bedside, n, (%) 
Incision and drainage at OR, n (%) 
Wound debridement, n (%) 
Re-infection within 30 days, n, (%) 
 
115 (5.7) 
25 (12.8) 
7.4 (5.7) 
22 (11.3) 
8 (4.1) 
7 (3.6) 
106 (54.1) 
37 (18.9) 
68 (34.7) 
9 (4.6) 
22 (11.2) 
 
54 (27.7) 
5 (2.6) 
2.7 (2.2) 
7 (3.6) 
0 (0) 
1 (0.5) 
118 (60.5) 
88 (44.9) 
76 (38.8) 
6 (3.1) 
8 (4.1) 
 
<0.001 
<0.001 
<0.001 
0.003 
<0.001 
0.034 
0.199 
<0.001 
0.402 
0.300 
0.006 
Note. The Charlson Comorbidity Index predicts the one-year mortality for a patient with a 
range of comorbid conditions. Chi-square or Fisher’s Exact test was used for categorical 
variables and Mann-Whitney U test was used to analyze continuous variables. 
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Figure 2. Infection type comparisons between ABSSSI + BSI and ABSSSI. 
 
Figure 3. Comparison of comorbidities for ABSSSI + BSI and ABSSSI patients. 
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Figure	4.	Antibiotic	Treatment	
 
Figure 4. Comparison of antibiotic treatment for ABSSSI + BSI versus ABSSSI patients. 
Table 6 displays the results of the logistic regression analysis of all demographic, 
sociodemographic, and clinical characteristics that met the minimal p value of < 0.1 via 
bivariate analysis.  According to the results from the logistic regression analysis, males 
had higher odds of being ABSSSI + BSI than females; with an aOR of 1.85, 95% CI 
1.11-3.66 had acute renal failure, aOR 2.08, 95% CI 1.18-3.67 (p = 0.011), and abused 
intravenous drugs, aOR 4.38, 2.22-8.62 (P < 0.001).  Additional risk variables that 
remained in the model and were significant for ABSSSI +BSI included prior 
hospitalization within 180 days of hospital admission with an aOR of 2.41, 95% CI 1.24-
4.93 (p = 0.01); abnormal temperature, aOR 2.86, 95% CI 1.66-4.93 (p < 0.001); and, 
elevated WBC count, aOR 4.26, 95% CI 2.43-7.47 (p < 0.001) compared to individuals 
with ABSSSI.  Compared to ABSSSI + BSI, individuals who had ABSSSI and abscess or 
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abscess and cellulitis were protected from bloodstream infection with an aOR of 0.220, 
95% CI 0.11-0.46 and aOR 0.139, 95% CI 0.07-0.28 (p < 0.001), respectively.  The 
Hosmer-Lemeshow goodness of fit test was not significant (p = 0.305) indicating that 
there was no evidence of a lack of model fit.  On the basis of these findings, Research 
Question 1 hypothesis was rejected, and the alternative hypothesis was accepted 
indicating that patients with ABSSSI-associated BSIs had significant differences in 
sociodemographic and clinical factors compared to patients with ABSSSI. 
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Table 6 
Logistic Regression Analysis of Patient Risk Factors for ABSSSI+BSI 
 
Factor Unadjusted OR 95% 
Confidence 
Interval 
Adjusted OR 95% 
Confidence 
Interval 
Sex (Male) 1.74 1.16-2.61 1.85 1.11-3.66 
High School >30% < HS by 
Zip Code 
2.10 0.92-4.80 2.91 0.98-8.64 
Acute Renal Failure 3.08 2.0-4.74 2.08 1.18-3.66 
IV Drug Use 1.98 1.16-3.39 4.38 2.22-8.62 
Charlson Comorbidity Index 1.29 1.18-1.42 1.13 0.99-1.28 
Prior Hospitalization within 
180 days 
3.24 1.93-5.43 2.41 1.24-4.70 
Abnormal Temperature 3.25 2.07 2.86 1.66-4.93 
Elevated WBC 2.75 1.81-4.16 4.26 2.43-7.47 
Abscess 0.659 0.432-1.01 0.220 0.11-0.46 
Abscess + Cellulitis 0.420 0.28-0.64 0.139 0.07-0.28 
Hosmer-Lemeshow p = 0.305 
Note. High school > 30% <HS by zip code= indicates a zip code where >30% of population of 
has not completed high school, Charlson comorbidity index predicts the 1-year mortality for a 
patient with a range of comorbid conditions, abnormal temperature = temperature > or < 98.60 F, 
elevated WBC = WBC count > 11 x 109 cells/liter.  Referent group for the following covariates 
are listed here: male versus female, high school < 30% by zip code versus all other zip codes, 
acute renal failure versus no renal failure, IV drug use versus no drug use, Charlson comorbidity 
index; individuals grouped by scores (0-4 and > 4) referent group < 4, prior hospitalization 
within 180 days versus no hospitalization, abnormal normal temperature and elevated WBC 
versus normal temperature and WBC, abscess or abscess + cellulitis versus all other types of 
infection. 
 
Research Question 2 and Hypothesis 
2. Is race/ethnicity associated with disease severity (based upon surgical 
interventions [e.g., incision and drainage, wound debridement, 
amputation, shock or admission to the ICU]) among ABSSSI-associated 
BSI? 
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H02: Race/ethnicity is not associated disease severity (based upon surgical 
interventions [e.g., incision and drainage, wound debridement, amputation, shock, or 
admission to the ICU]) among patients with ABSSSI-associated BSI. 
Ha2: Race/ethnicity is associated with disease severity (based upon surgical 
interventions [e.g., incision and drainage, wound debridement, amputation, shock, or 
admission to the ICU]) among patients with ABSSSI-associated BSI. 
 The second research question in this study was designed to evaluate whether race 
and ethnicity had an impact on the severity of diseases.  Analysis of this question by 
bivariate analysis using chi-square or Fisher’s exact test for categorical variables and 
Mann-Whitney U test for continuous variables is displayed in Table 7.  I found that, 
compared to all other race/ethnicities, African Americans had a higher percentage (66.9 
versus 48.3%, p<0.001) of severe disease versus nonsevere disease, whereas individuals 
who were European American had a low rate of severe disease (47 versus 99%, p = 
0.002) compared to other race/ethnicities.   
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Table 7 
Demographic, Sociodemographic, and Clinical Characteristics by Severity 
 
Variables Nonsevere 
n = 226 
Severe 
n = 166 
p Value 
Age (yr.), mean+/-(SD) 48.5 (18.1) 49.3 (16.2) 0.645 
Gender, n, (%) 
Male 
Female 
 
140 (61.9) 
86 (38.1) 
 
92 (55.4) 
74 (44.6 
0.213 
Race, n, (%) 
African-American 
Asian 
Caucasian 
Other 
 
109 (48.3) 
2(0.9) 
99 (43.2) 
16 (7.1) 
 
111 (66.9) 
0 (0.0) 
47 (28.3) 
8 (4.8) 
 
<0.001 
0.510 
0.002 
0.401 
Sociodemographics by zip code, n, (%) 
Education >30% No High School 
Median Income < poverty 
Medical Insurance, n, (%) 
 
18 (8.0) 
85 (37.6) 
42 (18.6) 
 
9 (5.4) 
55 (33.1) 
33 (18.9) 
 
0.420 
0.394 
0.795 
BMI>30 kg/m2, n, (%) 93 (41.7) 77 (47.2) 0.300 
Abnormal Temperature, n, (%)  62 (27.4) 62 (37.3) 0.024 
Elevated WBC, n, (%) 113 (50.0) 116 (69.9) <0.001 
Acute Renal Failure, n (%) 73(32.3) 73 (44.0) 0.012 
Type of ABSSSI, n (%) 
Abscess 
Cellulitis 
Abscess + Cellulitis 
Infected Wound 
Ulcer 
 
75 (33.26) 
66 (29.2) 
73 (32.3) 
12.0 (5.3) 
0.0 (0.0) 
 
55 (33.1) 
10 (6.0) 
83 (50) 
16 (9.6) 
2 (1.2) 
 
0.540 
<0.001 
<0.001 
0.114 
0.179 
Infection Site, n, (%) 
Upper Extremity 
Lower Extremity 
Head/Neck 
Torso/Trunk 
 
69 (30.5) 
93 (41.2) 
32 (14.2) 
32 (14.2) 
 
42 (25.3) 
74 (44.6) 
19 (11.4) 
31 (18.7) 
0.400 
Methicillin-Resistant S. aureus, n, (%) 156 (69.0) 122 (73.5) 0.369 
Polymicrobial, n, (%) 19 (8.4) 24 (14.5) 0.071 
Comorbidities 
Chronic Renal Failure, n, (%) 
Hepatic Disease, n, (%) 
Diabetes, n, (%) 
Paraplegia, n, (%) 
Hypertension, n, (%) 
Congestive Heart Failure, n, (%) 
IV Drug Use, n, (%) 
 
16 (7.1) 
15 (6.6) 
67 (29.6) 
1 (0.4) 
79 (35.0) 
12 (5.5) 
37 (16.4) 
 
17 (10.2) 
8 (4.8) 
58 (34.9) 
3 (1.8) 
62 (31.6) 
14 (8.4) 
32 (19.3) 
 
0.265 
0.519 
0.266 
0.315 
0.116 
0.226 
0.455 
Charlson Comorbidity Indexa, median, (IQR) 2 (0-4) 2 (1-5) 0.369 
Corticosteroids, n, (%) 1 (0.4) 2 (1.2) 0.576 
Prior hospitalization 180 days, n, (%)    63 (32.1) 45 (27.1) 0.058 
Prior antibiotic use past 30 days, n (%) 14 (6.2) 20 (12.0) 0.042 
Prior MSSA infection 60 days, n, (%) 6 (2.7) 12 (7.2) 0.408 
Prior MRSA infection 60 days, n, (%) 11 (5.6) 7 (3.6) 0.033 
History of ABSSSI past 60 days, n,(%) 16 (7.1) 20 (12.0) 0.092 
Note. The Charlson comorbidity index predicts the one-year mortality for a patient with a range of comorbid 
conditions. 
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Table 8 displays the results of the logistic regression analysis of ABSSSI + BSI 
and ABSSSI patient risk factors by severity.  After controlling for confounding variables, 
African American race and elevated WBC count remained in the model and were 
significantly (p=0.001) associated with severe infection, aOR 2.18, 95% CI; 1.38-3.4 and 
aOR 2.24, 95% CI; 1.41-3.55, respectfully.  In addition, prior hospitalization within 180 
days of admission was also significantly (p=0.010) associated with severe disease, aOR, 
2.07, 95% CI; 1.19-3.  Although renal failure and polymicrobial ABSSSI had an 
increased association with severe infection (i.e., with aOR of 2.26, 95% CI; 0.932-5.5 and 
aOR of 1.87, 95% CI; 0.930-3.74), these were not statistically significant (p=0.071, 
0.079).  On the basis of these findings, Research Question 2 and Hypothesis 2 was 
rejected, and the alternative hypothesis was accepted indicating that race/ethnicity was 
associated with disease severity (based upon surgical interventions [e.g., incision and 
drainage, wound debridement, amputation, shock, or admission to the ICU]) among 
patients with ABSSSI-associated bloodstream infections. 
77 
 
Table 8 
Logistic Regression Analysis of Patient Risk Factors by Severity 
Factor Unadjusted OR 95% 
Confidence 
Interval 
Adjusted 
OR 
95% Confidence 
Interval 
African American 2.17 1.43-3.28 2.18 1.38-3.44 
Elevated WBC 2.32 1.52-4.5 2.24 1.41-3.55 
Acute Renal Failure 1.50 0.73-3.06 2.26 0.932-5.49 
Cellulitis 0.155 0.087-0.31 0.202 0.92-0.44 
Abscess + Cellulitis 3.0 1.39-3.17 1.65 1.03-2.65 
Polymicrobial 1.84 0.97-3.49 1.86 0.930-3.74 
Prior Hospitalization 
180 days 
1.58 0.98-2.56 2.07 1.193-3.59 
Hosmer-Lemeshow p = 0.843 
Note. Referent groups for the following covariates are listed here: African Americans 
versus all other races, elevated WBC > 11 x 109 cells/ L versus < 11 x 109 cells/L, acute 
renal failure versus no renal failure, cellulitis and abscess + cellulitis versus all other skin 
infection types, polymicrobial infection versus all other types of infection, prior 
hospitalization 180 days versus no infection. 
 
Summary 
In Chapter 4, I provided an overview of the data results analyzed for this research 
investigation.  With regards to the first research question on whether sociodemographic 
and clinical factors differed between patients with ABSSSI + BSI and ABSSSI, I found 
that there were several factors that were associated with ABSSSI + BSI including the 
presence of acute renal failure, a history of intravenous drug use or prior hospitalization, 
and abnormal temperature and elevated WBC count.  ABSSSI that was classified as 
abscess or abscess plus cellulitis appeared to be protective.  With regards to the second 
research question on whether race and ethnicity was associated with severity of disease, 
African Americans were more likely to have a more severe disease.  An elevated WBC 
count on admission, a history of prior hospitalization, and the diagnosis of abscess + 
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cellulitis were also associated with severe disease.  In Chapter 5, I will provide an in-
depth discussion of the results and their implications as well as concluding statements, 
intervention recommendations, and the impact of these findings on social change. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this investigation was to determine the risk factors that were 
associated with patients who had Staphylococcus aureus ABSSSI with BSI versus 
individuals who had ABSSSI without BSI from the city of Detroit.  The study design was 
a case control retrospective evaluation.  Data collection consisted of evaluating electronic 
medical charts from two medical centers from January 2010 until December 2015.  The 
DMC and HFH are major medical centers located in downtown Detroit that serve the 
population of Detroit as well as the surrounding Detroit Metropolitan areas.  ABSSSI + 
BSI (cases) were defined as an individual who had ABSSSI + BSI with BSI diagnosed 
within 48 hours of hospital admission.  Individuals with ABSSSI but without BSI served 
as the study controls (Lipsky, Kollef, et al., 2010).  Overall, 392 patients (196 cases, 196 
controls) who were diagnosed with ABSSSI + BSI and ABSSSI made up the study 
population.  Descriptive statistics and logistic regression models were used to analyze 
Research Question 1 and 2 that dealt with the risk factors for ABSSSI + BSI as well as 
determining the impact of race and ethnicity on the severity of disease.  BSIs are 
associated with serious complications including mortality.  Evaluating risk factors that 
maybe unique to the population of Detroit was important to identify potential cases early 
and to direct optimized medical intervention to avoid these complications.  In addition, 
determining whether race and ethnicity had an impact on the severity of disease was 
important because the city of Detroit has a predominant African American population, 
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and this underserved population has been previously reported to have higher rates of 
medical complications. 
Interpretation of Findings 
Research Question 1 
 The first research question was designed to determine if there were risk factors for 
patients who had ABSSSI and acquired BSI who resided in intercity Detroit.  This was 
accomplished by determining if there were any significant differences in clinical or 
socioeconomic factors between patients with ABSSSI and ABSSSI with BSI.  Although 
limited data exist, several researchers have examined the relationship between patient 
characteristics and BSI in individuals with ABSSSI, which included the acquisition of 
MRSA from the community (Tattevin et al., 2012), old age, male sex, coronary heart 
disease, the presence of infected prosthetic devices, health care-associated infections, 
abnormal WBC counts, and vital signs such as temperature (Lipsky, Kollef, et al., 2010).  
However, these investigations included patients who acquired their infection in the 
hospital, making it difficult to extrapolate these findings to community-acquired ABSSSI 
with BSI.  In addition, the contribution of socioeconomic factors was not examined.  I 
also found that older age, male gender, abnormal temperature, and elevated WBC count 
on hospital admission was significantly associated with ABSSSI with BSI by descriptive 
statistical analysis (Table 2).  Other factors that were statistically significant for ABSSSI 
with BSI was the presence of MRSA, prior hospitalization within the last 180 days, and 
prior MSSA infection within the last 60 days.  In addition, < 30% high school education 
by zip code was significantly associated with ABSSSI with BSI.  Although income and 
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other sociodemographic characteristics had been previously evaluated for MRSA 
infections, the relationship between education level and ABSSSI with BSI had not been 
reported previously.  In the present study, there were a number of comorbid conditions 
(Table 3) that were found to be associated with ABSSSI with BSI such as acute and 
chronic renal failure, hepatic disease, diabetes, hypertension, congestive heart failure, and 
IV drug use.  Several of these factors had been previously reported.  However, these 
scholars focused only on hospitalized patients and, therefore, the data may not be 
generalizable to patients who derived BSI in the community (Lipsky, Kollef et al., 2010).  
The number of comorbid conditions present on admission was significant for ABSSSI 
with BSI and, though this relationship has not been previously reported, it may be useful 
for predicting whether a patient may be at increased risk for ABSSSI with BSI.  As 
expected, a significantly higher percentage of patients with ABSSSI with BSI required an 
infectious disease consult, were admitted to the ICU, deemed a failure at time of 
discharge, and had a higher rate of mortality and reinfection within 30 days of discharge.  
After adjusting for confounding variables in a logistic regression model (Table 4), male 
sex, high school < 30% by zip code, acute renal failure, Charlson comorbidity index, IV 
drug use, prior hospitalization within the last 180 days, abnormal temperature, and 
elevated WBC were independent predictors of ABSSSI with BSI.  Further, abscess or 
abscess plus cellulitis appeared to have a protective effect (aOR 0.220, 0.139, 
respectively).  The most probable explanation for this protective effect may be related to 
routine medical intervention that commonly includes surgical incision and drainage of the 
abscess.  In many cases, this removes the focus of the infection and, therefore, likely 
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protects the patients from BSI as a complication of ABSSSI (Moran et al., 2013; Pollack, 
et al., 2015; Stevens et al., 2014). 
Research Question 2 
 In the second research question, I evaluated whether race/ethnicity was associated 
with disease severity.  A composite definition was used to define severity, which 
consisted of incision and drainage in the operating room, wound debridement, 
amputation, and admission to the ICU or shock with patients with ABSSSI or ABSSSI-
associated BSI.  African Americans have significantly higher rates of SSTIs compared to 
European Americans (Ray et al., 2013a).  In general, African Americans of low 
socioeconomic status have a higher rate of persistent infection, higher readmission rates, 
and increased infection complications (Acosta et al., 2013; Morris et al., 2014; Zajacova, 
Dowd, & Aiello, 2009).  However, the impact of ethnicity on severity of disease in 
patients with ABSSSI and ABSSSI with BSI has not been evaluated.  
 In the current study, when the cohort was evaluated by bivariate analysis on the 
basis of severity, African Americans had a significantly higher amount of cases classified 
as severe (66.9 versus nonsevere 48.3%) while European Americans had a significantly 
lower amount of cases classified as severe (28.3 versus 43.8%, respectively).  Besides 
having abnormal temperature and elevated WBC on admission, individuals with more 
severe disease had a higher percentage of acute renal failure as well as a higher 
percentage of cellulitis and abscess and prior antibiotic use in the past 30 days.  When 
evaluated by logistic regression controlling for potential confounding, African American 
race, elevated WBC, the presence of abscess plus cellulitis, and prior hospitalization 
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within the past 180 days remained in the model and had a significantly higher odds of 
having more severe disease than other groups.  Individuals diagnosed with cellulitis 
without abscess had a significantly lower odds ratio (aOR 0.202) for severe disease, 
which may indicate that cellulitis without abscess may have a protective effect.  
Individuals with abscess are more likely to have surgical drainage as a part of their 
treatment intervention.  Surgical drainage removes the foci of infection and improves the 
likelihood of antibiotic success (Moran et al., 2013; Pollack, 2015; Stevens, 2014).  This 
procedure likely prevents patients’ localized infection (abscess) from spreading into the 
surrounding tissue causing cellulitis and potentially BSI.  Individuals with abscess and 
cellulitis already have an extensive infection that has spread into the surrounding tissues 
and, thus are, more likely to acquire BSI. 
Theoretical Framework 
 The theoretical framework that was chosen for this study was the web of 
causation.  Causation is the event or condition that leads to the outcome of interest.  It 
provides a mechanism that helps to explain the process that leads to the development of 
disease.  Preceding events or conditions lead to the outcome of interest (Kreiger, 1994).  
Disease development can be related to a variety of factors including underlying genetic 
abnormalities, microorganisms, environmental factors, and social and behavioral 
characteristics (Norton, 2015).  In the present study, the web of causation applied because 
the mechanisms in which a patient with ABSSSI acquires BSI had not been defined.  
Although BSI is known to be a severe complication of ABSSSI, the underlying patient 
characteristics and conditions that lead to BSI are not known.  Further, it is not known if 
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sociodemographic conditions or race/ethnicity may contribute to the acquisition of BSI or 
the severity of the disease. African-American race, diabetes, renal failure, hypertension, 
congestive heart failure, intravenous drug use, prior MRSA infections, prior 
hospitalization and antibiotic use are some of key risk factor findings in this study that 
were linked to ABSSSI + BSI and severity of disease. Understanding the factors that 
contribute to ABSSSI and ABSSSI with BSI—especially as it relates to a relatively 
underserved population in the city of Detroit—is important for prevention and treatment 
interventions that could avoid these complications.  
Limitations of the Study 
 This study was a retrospective study design and, therefore, was subject to all of 
the potential biases associated with this type of investigation.  For example, it was 
possible that there may be missing or incomplete data recorded in the medical charts.  
While it appeared that incomplete or missing data was minimal during the data collection, 
it is possible that some data was not recorded or was recorded incorrectly. Another 
potential limitation was the assumption that in patients with the diagnosis of cellulitis and 
BSI, the S. aureus identified in the bloodstream originated from the patient’s cellulitis.  
Cellulitis is a deep-seated infection of the subcutaneous tissues of the skin and, thereby, 
difficult to culture the pathogen causing disease.  While S. aureus is a pathogen 
associated with cellulitis, other bacterial pathogens such as streptococci are also a 
frequent cause of cellulitis (Dryden, 2010; Stevens et al., 2014).  Therefore, although 
unlikely, cases of BSI where cellulitis without abscess was identified as the infection type 
may have been misclassified.  Additionally, I evaluated the impact of race and ethnicity 
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on severity of disease.  The composite definition for severity included amputation.  
However, there were no amputations recorded in the population cohort.  It was possible 
that the exclusion of diabetic foot infections from this study may be the most likely 
reason for the lack of amputations because surgical intervention including amputation is 
common among this population.  Further, one of the objectives of this investigation was 
to determine whether sociodemographic characteristics were associated with ABSSSI 
with BSI.  However, this information was derived by zip code that was provided through 
federal census data.  Individual information on education and level of income was not 
available on an individual basis; therefore, the information was limited.  Lastly, the study 
was conducted on a population of individuals who reside in Detroit or its immediate 
surrounding areas.  It is possible that the results of this investigation cannot be 
extrapolated to other metropolitan populations. 
Recommendations for Future Research 
 Although a number of potential risk factors that may be associated with ABSSSI 
with BSI were identified in this investigation including race, additional research should 
be explored elsewhere to confirm that race or access to medical care is the most likely 
explanation for this finding.  African Americans have been previously identified as at risk 
for a number of infection related diseases and complications (Klevens, et al., 2007; Ray 
et al., 2012).  However, it is unclear whether this finding is related to race/ethnicity issues 
or lower socioeconomic status in this population and, therefore, poor access to medical 
care.  Although < 30% high school education by zip code was significantly associated 
with ABSSSI and BSI, level of income was not.  It was possible that the measurement of 
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these factors by zip code may not be sensitive enough to delineate a relationship between 
sociodemographic characteristics and ABSSSI with BSI.  Future research investigating 
the relationship between ABSSSI with BSI and sociodemographic factors should evaluate 
this information on an individual basis.  Understanding the relationship between 
sociodemographic characteristics and complications of infection could lead to 
interventions including risk assessment for disease development. 
Recommendations for Future Action 
 In this study, I examined a population in urban Detroit Michigan at risk for 
ABSSSI and ABSSSI with BSI.  Although risk factors have been evaluated in patients 
hospitalized for ABSSSI, there are limited studies on the risk for BSI in patients with 
ABSSSI from the community (Lipsky, Kollef, et al., 2010).  In addition, there are no 
investigations on the risk for BSI in patients with ABSSSI from an urban environment 
such as Detroit.  It is important to evaluate intercity populations for disease risk for 
infection because these populations often are of lower socioeconomic status and, 
therefore, are at risk due to limited access to appropriate medical care (Khabbaz et al., 
2014; Lantz & Prichard, 2010).  Individuals of lower socioeconomic status are more 
likely to delay seeking medical attention and are at risk for increased complications 
including hospitalization, surgery, relapse, and readmission (Acosta et al., 2013; Ray et 
al., 2013a).  A delay in seeking medical attention for ABSSSI can lead to the acquisition 
of BSI with severe complications including mortality (Acosta et al., 2013; van Hal, 
2012).   
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Implications for Social Change 
 Patients with Staphylococcus aureus BSIs experience a high degree of 
complications including metastatic spread leading to severe life threatening infections 
(Corey, 2009; del Rio et al., 2009).  If not appropriately and promptly treated, mortality 
rates can range from 20-40% (Gould, 2007; Kobayashi, Yokota, Takahashi, Arioka & 
Fukui, 2014).  One of the most severe complications from ABSSSI is BSI.  The burden of 
infection is higher in non-Hispanic Blacks and Mexican Americans (Zajacova et al., 
2009).  In addition, higher readmission rates, risk of infection, and sepsis have been 
reported among African Americans (Acosta et al., 2013; Morris et al., 2014).  
Understanding the characteristics and risks associated in patients with ABSSSI with BSI 
is important to identify the most appropriate intervention to prevent and reduce these 
complications.  There is a need to direct medical resources and social support to 
individuals in intercity Detroit who are at risk for ABSSSI and BSI.  Partnerships 
between community organizations, public health authorities, and intercity hospitals are 
needed to educate, screen, and identify individuals at risk to prevent these infections in 
this patient population.  
Conclusion 
The acquisition of BSI secondary to ABSSSI can be severe and include a variety 
of complications such as spread of infection to other vital organs and tissues, sepsis, and 
shock leading to death.  Understanding the risk factors associated with BSI can lead to 
preventive interventions to reduce complications including mortality.  This is particularly 
important in patient populations of low socioeconomic status because they have been 
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demonstrated to have worse clinical outcomes.  While this relationship has been 
previously reported, there is little to no information in patients with low socioeconomic 
status diagnosed with ABSSSI and BSI.  Therefore, a knowledge gap existed regarding 
this patient population and BSI secondary to ABSSSI.  In this study, I identified a 
number of patient characteristics, including sociodemographic factors such as level of 
education, that may contribute to BSI in patients with ABSSSI.  In addition, several 
factors including African American race was associated with a higher degree of infection 
severity.  According to these findings, there is a need to include sociodemographic 
characteristics when evaluating patient health outcomes.  Further research is warranted to 
more fully characterize these risks to prevent these complications in this vulnerable 
patient population. 
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